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ABSTRACT 
 
Peripheral arterial disease (PAD) and its symptomatic form, chronic lower limb ischemia, present a 
growing challenge for the health care system in the western world due to the aging of the 
population. There is an increasing need to weigh the risks of the invasive treatments for PAD 
against the possible benefits of the same in terms of patient survival and quality of life. In addition 
to the anatomic locations of PAD lesions that determine what kind of treatment can be used, there 
are several quite well-known risk factors affecting the decision-making process. 
   
The aim of the present study was to investigate the anatomical distribution of PAD lesions and the 
role of diabetes as a risk factor for surgery on critical limb ischemia, in addition to studying a 
possible model for identifying high-risk patients for surgery as well as examining the impact of 
endovascular treatment for chronic lower limb ischemia on the quality of life.   
 
For the analysis of the anatomical locations of PAD lesions, 98 consecutive patients’ (38 diabetics 
and 60 non-diabetics) digital subtraction angiographies were evaluated. The risk factors and 
outcomes after vascular surgical procedures were evaluated in two studies – the first was based on 
the retrospective Finnvasc national registry’s 5,709 surgery patients operated for critical limb 
ischemia, and the second was a prospective clinical study on 157 consecutive patients undergoing 
vascular surgery. The impact of PTA (percutaneus transluminal angioplasty) treatment of chronic 
lower limb ischemia on clinical outcome and quality of life was investigated in a prospective 
clinical study including 61 consecutive patients undergoing PTA and suffering from claudication or 
critical limb ischemia. 
    
As a result for the locations of PAD lesions, diabetics had less stenosis in the superficial femoral 
artery, but they had a tendency towards more diffuse atherosclerotic disease in their crural arteries. 
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In the multivariate analysis of the Finnvasc registry patients regarding the risks of surgery, diabetes 
was not an independent risk factor for early postoperative mortality in CLI, but morbidity was 
increased among diabetics in association with definitive risk factors. In a further study of risk 
factors and outcome after vascular surgery, the Glasgow Aneurysm Score (GAS) proved to have a 
good predictive value for outcome after vascular surgery among low-risk patients (GAS<77), but 
due to its low predictive value for death, GAS yields limited value in clinical practice. In the study 
on 61 PTA-treated patients, the impact of the treatment on the quality of life was examined using 
the Finnish version of the Nottingham health profile. For the claudicants, treatment resulted in an 
immediate improvement in the quality of life, but this effect seemed to vanish in the long term. 
However, there is a subgroup of CLI patients, for whom PTA led to significant benefits in terms of 
both limb salvage and quality of life.   
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1 INTRODUCTION AND REVIEW OF THE LITERATURE 
 
1.1 Peripheral arterial disease 
 
1.1.1 Introduction 
 
Peripheral arterial disease (PAD) is a progressive atherosclerotic disease resulting in arterial 
stenosis and occlusions in non-coronary or non-carotid arteries. PAD is most often asymptomatic, 
and the most common clinical manifestation, due to its typical manifestation in at least one major 
vessel supplying the lower extremities, is chronic lower limb ischemia, intermittent claudication 
(IC), or critical limb ischemia (CLI). Sometimes the first clinical symptom is acute ischemia.  
 
The total prevalence of asymptomatic PAD, as based on objective testing, has been evaluated in 
several epidemiologic studies and is in the range of 3%–10%, increasing to 15%–20% in persons 
aged over 70 years (Criqui et al., 1985, Hiatt, Hoag and Hamman, 1995, Selvin and Erlinger, 2004, 
Sigvant et al., 2007). Because the majority of patients are asymptomatic, the prevalence of PAD in 
the leg can only be estimated by using objective measurements in a general population. The ankle-
brachial index (ABI) is a reliable non-invasive means to diagnose PAD. A resting value of ≤ 0.9 is 
most often used in epidemiological studies as a threshold value for the presence of PAD, with 80%–
90% sensitivity and 95%–100% specificity (Guo et al., 2008, Norgren et al., 2007). 
 
Although PAD is relatively common among the elderly population, the prevalence of symptomatic 
PAD is much lower (Diehm et al., 2004a). On the other hand, typical claudication symptoms may 
not occur in patients who have co-morbidities that prevent sufficient activity to produce limb 
symptoms or in patients who are too sedentary to walk (Norgren et al., 2007). 
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1.1.2 Claudication 
 
IC is considered the most classic manifestation of PAD. IC usually refers to cramping pain in the 
musculature of the legs during exercise, and the pain is relieved within 10 minutes’ rest from 
exercise (Norgren et al., 2007, Laing and Greenhalgh, 1980a). The pain is caused by an occlusive or 
stenotic lesion in the arterial supply of the leg muscles that interferes with the blood flow, 
producing ischemic pain with exercise. The localisation of the symptoms depends on the level of 
stenosis or occlusion in the arterial tree. Patients with an isolated occlusion of an internal iliac artery 
may have claudication in the buttocks, and impotence may occur in males. Occlusion or stenos of 
the common or external iliac artery may cause symptoms in the thigh and occlusion or stenosis of 
the femoral arteries in the calf. (Norgren et al., 2007). Based on several large population studies, the 
prevalence of  IC is estimated to increase from roughly 3% in patients aged 40 to 6% in patents 
aged 60 years (Norgren et al., 2007)(Reunanen, Takkunen and Aromaa, 1982)(Hughson, Mann and 
Garrod, 1978)(Hirsch et al., 2001). 
 
Although PAD is progressive in the pathological sense, the clinical course of claudication is stable 
in most cases, and approximately one quarter of patients with IC will deteriorate significantly 
(Norgren et al., 2007). From these 25%, only roughly 5%–10% will progress to critical limb 
ischemia over a 5-year period (Hirsch et al., 2006) . 
 
1.1.3 Critical limb ischemia 
 
The term CLI refers to a severe clinical manifestation of PAD, such as chronic ischemic rest pain 
and/or ischemic skin lesions, either ulcers or gangrene, with symptoms that have been present for 
more than 2 weeks with objectively proven arterial disease (Norgren et al., 2007). The reduction of 
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blood supply threatens the leg, and without revascularisation, approximately 40% of the patients 
will have to undergo a major amputation and 20% will die within six months (Norgren et al., 2007, 
Rutherford et al., 1997a). Fontaine's stages and Rutherford's categories are widely used for the 
classification of PAD (Table 1). No absolute level of ABI or toe pressure (TP) can be set to indicate 
critical limb ischemia, but as a rough reference point, rest pain starts when ABI is below 40 mmHg 
or TP below 30 mmHg (Rutherford et al., 1997a). When a tissue lesion is present, higher pressure 
values have been proposed to fulfil CLI criteria, with ABI < 60 mmHg and TP < 40 mmHg 
(Rutherford et al., 1997a). The exact incidence of CLI is unknown. Patients will undergo a variety 
of medical treatments before their PAD has reached the stage of CLI. There is indirect evidence 
from studies looking at the progression of IC, in addition to population surveys on prevalence and 
assumptions based on amputation rates. Based on these studies, there are approximately 500–1,000 / 
million new cases of CLI every year in the European or North American population. (Dormandy, 
Heeck and Vig, 1999)(Norgren et al., 2007). 
 
 
 
Fontaine  
 
Rutherford  
 
Stage Clinical Grade Category Clinical 
I Asymptomatic 0 0 Asymptomatic 
IIa Mild claudication I 1 Mild claudication 
IIb Moderate to severe claudication I 2 Moderate claudication 
  I 3 Severe claudication 
III Ischemic rest pain II 4 Ischemic rest pain 
IV Ulceration or gangrene III 5 Minor tissue loss 
  III 6 Major tissue loss 
 
 
 Table 1. Classification of peripheral arterial disease: Fontaine's stages and Rutherford's categories. 
(Modified from: TASC working group 2007). 
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1.2 Risk factors for PAD 
 
PAD is highly associated with traditional cardiovascular disease risk factors. It is essential to 
understand that in most cases the progression of PAD is the sum of various risk factors rather than a 
consequence a certain risk factor (Figure 1). It is also important to identify these risk factors, 
because influencing them lowers the total cardiovascular risk in PAD patients, and the progression 
of PAD may also decrease (Hirsch et al., 2006). Patients with PAD have a high overall risk of death 
from cardiovascular causes (Criqui et al., 1992). 
 
 
 
 
Figure 1. Approximate range of odds ratios for the risk factors of symptomatic peripheral arterial 
disease. (Modified from TASC working group 2007.) 
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1.2.1 Smoking 
 
Current smoking is highly associated with PAD, and this relation was first recognised in 1911 by 
Erb, when the risk of IC was reported to be three times greater in smokers (Erb, 1911). In the 
Framingham study, the risk of PAD was documented to be twice as high in smokers when 
compared with non-smokers (Kannel, Castelli and McNamara, 1968). This finding has been 
confirmed by several other epidemiological studies, the relative risk ratios ranging from 1.7 to 7.5 
(Reunanen, Takkunen and Aromaa, 1982, Hughson, Mann and Garrod, 1978, Schroll and Munck, 
1981, Gofin et al., 1987). In a recent study, He et al. (He et al., 2008) also showed a positive 
association between passive smoking and the prevalence of PAD. 
 
1.2.2 Diabetes 
 
Diabetes is highly associated with PAD, and a low ABI is highly prevalent in subjects with diabetes 
(Gordon and Kannel, 1972)(Mostaza et al., 2008). Diabetes increases the risk of PAD 
approximately three- to four-fold and the risk of IC two-fold (Norgren et al., 2007). Furthermore, in 
diabetic patients, the limb-salvage rate in CLI has been reported to be lower and the major 
amputation rate higher than in non-diabetic PAD patients (Gottsater, 2006). Insulin resistance has 
been established as a risk factor for PAD even in patients without diabetes, raising the risk by 
approximately 40%–50% (Muntner et al., 2005). 
 
The number of diabetics is increasing, and recent estimates suggest that 195 million people 
worldwide suffer from diabetes: This number will increase to 330 or perhaps to as high as 500 
million by 2030 (King, Aubert and Herman, 1998, Engelgau et al., 2004). Furthermore, several 
epidemiological studies estimate that up to 50% of all patients with type 2 diabetes are undiagnosed 
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(Borch-Johnsen et al., 1998)(Harris et al., 1998)(Rathmann et al., 2003), since they remain 
asymptomatic for many years.  
 
The nature of PAD is often more subtle in its presentation in diabetics, although the association 
with diabetes is well known. PAD in individuals with diabetes is usually accompanied by peripheral 
neuropathy with impaired sensory feedback. Therefore, a classic history of claudication may be less 
common and the patient may elicit more subtle symptoms, such as leg fatigue and slow walking 
velocity, and simply attribute this to getting older (American Diabetes Association, 2003). It has 
been reported that patients with diabetes and PAD experience worse lower-extremity function than 
those with PAD alone (Dolan et al., 2002) who suffer from claudication. For these reasons, a patient 
with diabetes and PAD may be more likely to present with an ischemic ulcer or gangrene than a 
patient without diabetes. 
 
Early diagnosis of PAD is extremely important in diabetic patients with regard to preventing the 
progression of peripheral vascular disease. The vascular obstructions or stenosis in diabetics are 
often located more distally than in non-diabetics, being typically in the popliteal artery or in the 
crural arteries (Jude et al., 2001)(Strandness, Priest and Gibbons, 1964). The calcification of the 
media layer of the arteries is also a typical phenomenon of diabetic PAD (Everhart et al., 1988), 
which may cause a falsely high ABI index as a result of stiff arterial walls. On the other hand, it is 
important to consider that ulcers may often exist in a diabetic foot despite normal macrocirculation. 
These ulcers usually occur due to neuropathy, including disturbances in the microcirculation, as 
well as trauma and infection. (Boulton, 2008)(Jeffcoate et al., 2008).(Oyibo et al., 2001) Because 
the treatment of neuropathic ulcers is mainly non-surgical, the initial assessment must differentiate 
patients with a predominantly ischemic versus neuropathic cause. The provider must also establish 
the extent of any neuropathy or vascular disease (Adam, Raptis and Fitridge, 2006), which includes 
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testing for sensation, palpating for foot pulses, measuring the ABI and toe pressures, and often 
undertaking colour-flow duplex ultrasonography (Adam, Raptis and Fitridge, 2006, Cavanagh et al., 
2005). 
 
1.2.3 Age  
 
The prevalence of PAD increases with age, and in the highest age groups of 65–85 years, 20%–50% 
of the population are believed to have PAD, depending on the study design (Diehm et al., 2004a, 
Hirsch et al., 2001, Suominen et al., 2008a, Heidrich, Wenk and Hesse, 2004, Meijer et al., 1998). 
The prevalence of PAD peaks at the age of approximately 85 and decreases in nonagenarians to the 
level of 22%, being mostly asymptomatic (Suominen et al., 2008a). 
 
1.2.4 Dyslipidemia 
 
Hyperlipidemia is a well-established risk factor for PAD (Murabito et al., 1997) (Newman et al., 
1993), and accumulating evidence provides that treatment of hyperlipidemia reduces the 
progression of atherosclerosis in the peripheral arteries (Duffield et al., 1983)(Newman et al., 1993). 
According to the European guidelines of cardiovascular disease prevention in clinical practise (De 
Backer et al., 2003), total plasma cholesterol should be below 5.0 mmol/l and low-density 
lipoprotein cholesterol (LDL) below 3.0 mmol/l. For patients with established cardiovascular 
disease or diabetes, the threshold values are stricter: total cholesterol < 4.5 mmol/l and LDL < 2.5 
mmol/l (De Backer et al., 2003). In a recent study (Daskalopoulou et al., 2008), ABI correlated 
inversely with LDL levels in patients with newly diagnosed PAD who were not treated with lipid-
lowering drugs. An association between PAD and hypertriglyceridemia has also been reported and 
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shown to be associated with the progression and systemic complications of PAD (Norgren et al., 
2007). 
 
1.2.5 Sex 
 
The prevalence of PAD in the general population is slightly greater in men than women, particularly 
in the younger age groups (Norgren et al., 2007). Selvin et al. did not find clear sex-related 
differences in PAD prevalence in their study with 2,174 participants aged 40 years and older from 
the 1999–2000 National Health and Nutritional Survey (Selvin and Erlinger, 2004). In a recent large 
population-based study of PAD, Sigvant et al. revealed a new observation that women dominate 
among those with PAD when the definition is based only on ABI (Sigvant et al., 2007). In the 
GetABI study, the prevalence of both symptomatic and asymptomatic PAD was higher among men 
than women, but in an analysis of subjects over 85 years of age, the prevalence of both symptomatic 
and asymptomatic PAD was higher among women (Diehm et al., 2004b). Other studies have shown 
that women with PAD had a higher prevalence of leg pain on exertion and rest as well as poorer 
functioning and greater walking impairment due to leg symptoms than men with PAD (McDermott 
et al., 2003). In conclusion, in a younger population the prevalence of PAD is higher among men, 
but in a population aged over 85 years, the prevalence is higher among women. 
 
1.2.6 Renal insufficiency 
 
Many studies have reported both cross-sectional and longitudinal associations between baseline 
renal insufficiency and PAD (O'Hare et al., 2005)(Daskalopoulou et al., 2008). Among end-stage 
renal disease patients, the prevalence of PAD appears to be much higher than in the general 
population (O'Hare and Johansen, 2002). In a study with IC patients, Daskalopoulou found a 
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significant inverse correlation between ABI and serum creatinine level as well as estimated 
glomerular filtration rate (Daskalopoulou et al., 2008). 
 
1.2.7 Other risk factors  
 
Hypertension is a risk factor for cardiovascular diseases, both coronary heart disease (CHD) and 
cerebrovascular disease, as well as PAD (De Buyzere and Clement, 2008). The relative risk of 
developing PAD is lower in connection with hypertension as opposed to diabetes or smoking 
(Norgren et al., 2007), but hypertension and PAD combined cause a high total risk of cardiovascular 
events (De Buyzere and Clement, 2008)(De Buyzere and Clement, 2008) Several epidemiological 
surveys demonstrate a straightforward and independent relationship between increased blood 
pressure and the prevalence or incidence of PAD (De Buyzere and Clement, 2008). Especially 
systolic hypertension is characterised by the presence of PAD (Safar et al., 2008). 
 
The prevalence of hyperhomocysteinemia is high (5%–10%)(Humphrey et al., 2008) in the vascular 
disease population, while it is only 1% in the general population (Norgren et al., 2007). The 
association between PAD and hyperhomocysteinemia is strong, increasing especially the risk 
associated with smoking and hypertension. A high serum homocysteine concentration may be an 
independent risk factor for PAD, as well as for cerebrovascular disease and CHD (Graham et al., 
1997). A reduction of homocysteine levels has been accomplished by supplementation of the diet 
with vitamin B preparations (folate, vitamins B6 and B12), and in patients with hereditary 
homocystinuria, resulting in severe homocysteinemia (plasma concentrations >100 μmol/L), 
treatment with high-dose vitamin B in combination with dietary methionine restriction has resulted 
in a marked reduction of adverse vascular events (Yap et al., 2001). In contrast, results from trials 
aimed at lowering homocysteine levels in patients with mild hyperhomocysteinemia (10–30 
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μmol/L) have been disappointing, and the contradictory results have been attributed to trial design, 
with the potential adverse effects of vitamin B or homocysteine being rather a risk marker than a 
risk factor (Milani and Lavie, 2008)(Humphrey et al., 2008). 
 
The prevalence of PAD has been reported to vary somewhat by ethnicity, although published 
comparisons mainly concern non-Hispanics Whites, blacks, Hispanics and Asians (Ix et al., 2008). 
The National Health and Nutritional Survey in the United States found that ABI ≤ 0.90 was more 
common in non-Hispanic Blacks than in Whites (Selvin and Erlinger, 2004). The reason for the 
excess prevalence of PAD among African-Americans was thought to be a higher rate of associated 
risk factors such as diabetes and hypertension. It was also speculated whether the risk factors of 
PAD in African-Americans might represent less aggressive treatment of said risk factors. In a recent 
study by Criqui (Criqui et al., 2005), black ethnicity seemed to be a strong and independent risk 
factor for PAD, and it was not explained by higher levels of other known risk factors (Criqui et al., 
2005)(Ix et al., 2008). 
 
Plasma C-reactive protein (CRP) is a marker of underlying systemic inflammation. It is produced 
by the liver in response to cytokines, which increases in the presence of atherosclerosis and 
cardiovascular risk factors (Libby and Ridker, 1999). An elevated CRP level has been considered to 
be a risk factor for PAD (Pradhan, Rifai and Ridker, 2002, Rohde et al., 1998). A recent study by 
Dascapopoulou demonstrated that the ABI was significantly inversely correlated with creatinine, 
CRP and fibrinogen levels (Daskalopoulou et al., 2008). Zacho showed in his study that 
polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a 
theoretically predicted increase in the risk of ischemic vascular disease. However, these 
polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease 
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(Zacho et al., 2008). The elevated CRP level is therefore rather the indicator for PAD than a risk 
factor for the development of PAD.  
 
1.3 Diagnosis of PAD 
 
A thorough anamnesis combined with physical examination is the cornerstone when evaluating a 
patient with suspected PAD. The physical examination should assess the circulatory system as a 
whole, and the specific peripheral vascular examination requires palpation of pulses from the 
inguinal, popliteal and ankle levels. In younger patients with no PAD risk factors, pulse palpation 
enables physicians to exclude the diagnosis of PAD with a high degree of certainty (Stoffers et al., 
1997). On the other hand, despite the utility of the pulse examination, the finding of absent pedal 
pulses tends to over-diagnose PAD, whereas using the symptom of classic claudication to identify 
PAD will lead to a significant under-diagnosis (Schroll and Munck, 1981, Diehm et al., 2004b) 
(Norgren et al., 2007). Therefore, patients with a history or an examination suggestive of PAD, or 
when symptoms of CLI are suspected according to Fontaine's stages (Fontaine, Kim and Kieny, 
1954) and Rutherford's categories (Rutherford et al., 1997b)(table 1), PAD must be confirmed with 
objective testing. Non-invasive methods to confirm the diagnosis of PAD include ABI 
measurement, segmental limb pressures, pulse volume recordings, toe pressure, transcutaneous 
oxygen tension test, and stress test. 
 
1.3.1 Hemodynamic investigations 
 
Measuring the pressure in the ankle arteries has become a standard part of the initial evaluation of 
patients with suspected PAD. A common method of measurement uses a manometer cuff placed 
just above the ankle, with a Doppler probe used to measure the systolic pressure of the posterior 
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tibial and dorsalis pedis arteries of each leg (Figure 2). These pressures are then normalised to the 
higher brachial pressure of either arm to form the ABI, dividing the highest systolic blood pressure 
in the arteries at the ankle and foot by the higher of the two systolic blood pressures in the arms. An 
ABI ≤ 0.9 is typically considered diagnostic for PAD (Norgren et al., 2007), although the 
prevalence of PAD among people of an advanced age with elevated ABI (1.3–1.5) has lately been 
observed to be significantly probable especially among those with chronic renal failure, a history of 
smoking, CHD and severe lower extremity symptoms (Suominen et al., 2008b)  
 
 
 
 
 
Figure 2. Measurement of the ankle-brachial index (ABI). (Modified from TASC working group 
2007.) 
 
 
 
 
 23
1.3.2 Treadmill exercise test 
 
A treadmill exercise test as a measure walking distance or walking time is subject to a variety of 
errors, including the effect of learning, other manifestations of atherosclerotic disease and limited 
physical performance capacity, and, in this regard, it has proven unreliable (Laing and Greenhalgh, 
1980b, Perakyla et al., 1998).  The maximum walking distance measured by a progressive exercise 
test exhibits better reproducibility than any other direct measure of walking distance (Perakyla et 
al., 1998).  The treadmill test should be combined with other investigations, and the post-exercise-
test ABI has proven useful in screening arterial insufficiency in the lower limb (Lepantalo, Lindfors 
and Pekkola, 1983) . 
 
1.3.3 Imaging techniques 
 
Imaging of the lower limb arteries is indicated whenever some kind of revascularisation procedure 
is indicated, if a suitable lesion is localised for either an endovascular or open surgical technique. 
The current options for imaging are digital subtraction angiography (DSA), colour-assisted duplex 
ultrasonography (DD), magnetic resonance angiography (MRA) and computed tomography 
angiography (CTA). The sensitivity and specificity of DD, MRA and CTA, using the DSA as a 
golden standard, is 80%–95% in arterial stenosis and 90% –99% in occlusions (Adriaensen et al., 
2004)(AbuRahma, Khan and Robinson, 1995)(Hentsch et al., 2003)(Perreault et al., 
2003)(Portugaller et al., 2003). Potential side effects and contraindications should be considered in 
choosing the imaging modality, in addition to allowing for local availability, experience and cost.  
 
Angiography carries certain risks: an approximately 0.1% risk of severe reaction to contrast 
medium, a 0.7% risk severe enough to alter patient management, and a 0.16%  mortality risk 
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(Norgren et al., 2007). Other complications include arterial dissection, atheroemboli, contrast 
medium-induced renal failure as well as access site complications including pseudoaneurysm 
formation, arteriovenous fistula and haematoma (Norgren et al., 2007). CTA is less invasive than 
angiography, but the major limitations of CTA include the usage of iodine contrast medium and 
radiation exposure (Jakobs, Wintersperger and Becker, 2004).   
 
Colour-assisted ultrasonography is completely safe and much less expensive than the previously-
mentioned angiography and CTA or MRA, providing most of the essential anatomic and 
hemodynamic information. The lower extremity arterial tree can be visualised, with the extent and 
degree of lesions accurately assessed and arterial velocities measured. Proper examination of the leg 
demands experience and skill, and crural arteries are challenging to image in their entirety. 
(Norgren et al., 2007) .  
 
The advantages of MRA are safety and the ability to provide rapid high-resolution three-
dimensional imaging of the entire arterial tree in one setting without arterial puncture. The high-
field strength in MRA excludes patients with different variations of implants – for example, pace 
makers, spinal cord stimulators and intracerebral shunts – and the technique also excludes patients 
affected by claustrophobia that is not amenable to sedation. MRA is useful for treatment planning 
prior to intervention and in assessing the suitability of lesions for endovascular approaches, thus 
minimising the use of iodinated contrast medium and the exposure to radiation (Hentsch et al., 
2003)(Norgren et al., 2007) .  
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1.4 Conservative treatment of PAD 
 
1.4.1 Risk factor modification 
 
Patients with PAD typically have multiple cardiovascular risk factors, and an essential element of 
conservative treatment of PAD is to influence the risk factors. Alongside the actual treatment of 
PAD, risk factor modification diminishes the overall risk of cardiovascular events. Smoking 
cessation alone slows the progression of PAD in CLI and reduces the risk of death due to vascular 
causes (Girolami et al., 1999). With regard to the treatment of hyperlipidemia, the target value for 
low-density lipoprotein cholesterol should be less than 2.5 mmol/l and for total serum cholesterol 
under 4.5 mmol/l (De Backer et al., 2003)(Tikkanen et al., 2004). Although it is unclear whether 
aggressive blood glucose lowering will protect peripheral circulation and prevent amputation 
(Norgren et al., 2007), the target for patients with DM (diabetes mellitus) is a haemoglobin A1C 
level of less than 7.0%, and a level as close to 6.0% as possible should be targeted (Groop et al., 
2007).  Hypertension guidelines support the aggressive treatment of blood pressure in patients with 
PAD, and the current recommendation is a level of <140/90 mmHg and <130/80 if the patient also 
has DM or renal insufficiency (Bonny et al., 2008) (Jula et al., 2006).  
 
1.4.2 Antiplatelet therapy 
 
Aspirin is a well-recognised antiplatelet drug for secondary prevention that reduces the risk of 
adverse cardiovascular outcomes in patients with cardiovascular disease by approximately 25% 
(Antithrombotic Trialists' Collaboration, 2002). Current recommendations are to use antiplatelet 
therapy in all PAD patients with or without a history of other cardiovascular diseases (coronary or 
carotid arterial disease) to reduce the risk of cardiovascular morbidity and mortality, and the use of 
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aspirin should be considered in patients with PAD exhibiting no clinical evidence of other forms of 
cardiovascular disease (Norgren et al., 2007). According to numerous publications from the 
Antithrombotic Trialists' Collaboration, low-dose aspirin (75–160 mg) is protective and probably 
safer in terms of gastrointestinal bleeding than higher doses of aspirin (Antithrombotic Trialists' 
Collaboration, 2002). 
  
Clopidogrel has proven effective in reducing cardiovascular events in patients with PAD, with or 
without other clinical evidence of CHD (Norgren et al., 2007). The Clopidogrel Versus Aspirin in 
Patients at Risk if Ischaemic Events (CAPRIE) trial assessed the relative efficacy of Clopidogrel 
(75 mg/day) and aspirin (325/day) in reducing the risk of a composite outcome cluster of ischemic 
stroke, myocardial infarction or vascular death, and their relative safety was also assessed. The 
population studied comprised subgroups of 19,185 patients with atherosclerotic vascular disease 
manifested as either recent ischemic stroke, recent myocardial infarction or symptomatic PAD, and 
they were followed 1–3 years. There were 1,960 first events included in the outcome cluster, and 
patients treated with clopidogrel had an annual 5.32% risk of ischemic stroke, myocardial infarction 
or vascular death, as opposed to the 5.83% risk with aspirin. These rates reached a statistically 
significant (p = 0.043) relative risk reduction of 8.7% in favour of clopidogrel.(CAPRIE Steering 
Committee, 1996). 
 
The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and 
Avoidance (CHARISMA) trial assessed the combination of aspirin (75–162 mg/day) and 
clopidogrel (75 mg/day), n = 7 802, and the combination of aspirin and placebo, n = 7 801, for the 
prevention of atherothrombotic events in high risk patients. As a result, the combination of 
clopidogrel and aspirin was not significantly more effective than aspirin alone in reducing the rate 
of myocardial infarction, stroke or death from cardiovascular causes among patients with stabile 
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cardiovascular disease or multiple cardiovascular risk factors. Furthermore, the risk of moderate to 
severe bleeding was increased. (Bhatt et al., 2006). 
 
In a recommendation of the ACC/AHA Guidelines for the Management of Patients with Peripheral 
Arterial Disease, antiplatelet therapy is indicated to reduce the risk of myocardial infarction, stroke 
or death in individuals with PAD, and aspirin, in daily doses of 75–375 mg, is recommended as a 
safe and effective therapy. Clopidogrel (75 mg/day) is recommended as an effective alternative 
antiplatelet therapy to aspirin. (Hirsch et al., 2006). Oral anticoagulation therapy with warfarin is 
not indicated to reduce the risk of adverse cardiovascular ischemic events in individuals with PAD 
(Hirsch et al., 2006). 
 
1.4.3 Non-invasive treatment of claudication 
 
Patients with IC and PAD should all undergo the previously-mentioned risk factor modification 
treatment and antiplatelet therapy to reduce the risk of cardiovascular events. These activities, 
however, do not provide a significant reduction or elimination of the symptoms of IC. A number of 
medications have been developed for treating the symptoms of IC, with the phosphodiesterase type 
3 inhibitor cilostazol and the methylxanthine derative pentoxifylline in clinical use. At any rate, the 
evidence of clinical utility remains quite unsatisfying because of poor effect or danger of major side 
effects (Norgren et al., 2007)(Ferreira and Macedo, 2010).  
 
A supervised exercise programme for improving exercise performance and walking ability has been 
established by a considerable body of evidence to yield clinical benefits for the symptoms of IC 
(Gardner and Poehlman, 1995, Stewart et al., 2002)(Norgren et al., 2007). One meta-analysis 
(Gardner and Poehlman, 1995) that examined both randomised and non-randomised trials showed 
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that exercise training improved pain-free walking time by an average of 180% and maximal 
walking time by an average of 120%. Exercise-induced improvement in walking ability has proven 
to improve coping with routine daily activities (Clifford et al., 1980), and such increases in activity 
in association with improvements in cardiovascular risk factors might also reduce the risk of 
adverse cardiovascular events (Regensteiner, Steiner and Hiatt, 1996). However, there are no data 
to support the efficacy of general and unstructured recommendations by the physician, which is still 
the most typical exercise prescription for patients with claudication (Norgren et al., 2007, Stewart et 
al., 2002). 
 
1.5 Invasive treatment of PAD 
 
If, despite exercise, smoking cessation and risk factor modification, the patient’s quality of life is 
significantly reduced due to claudication, revascularisation procedures may be indicated, especially 
if the arterial lesion behind the symptoms is localised to the aortofemoral region. Three treatment 
methods are currently available: endovascular and surgical revascularisation or the combination of 
the same. The role of surgical bypass in claudication is poorly defined especially for infrainguinal 
disease. The morbidity and mortality associated with operating on a group of patients with a high 
prevalence of CHD, combined with the significant failure rate of bypass grafting, in a condition that 
has a relatively benign prognosis concerning the fate of the leg render this option very controversial. 
Single or multiple aortoiliacal stenosis totalling 10 cm and unilateral short (≤ 3 cm) occlusion is 
suggested for endovascular therapy (Norgren et al., 2007). For patients with disabling claudication 
and a low-risk profile, surgical revascularization may be considered in the case of severe 
aortofemoral lesions (Norgren et al., 2007).  
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The natural prognosis of CLI is such that intervention, endovascular or surgical, is indicated to 
salvage a useful and pain-free extremity. The treatment chosen always depends on the general 
condition of the patient and the extremity as well as an estimation of the risk of intervention based 
on co-morbid conditions and the expected patency and durability of reconstruction (Norgren et al., 
2007)(Figure 3). 
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Figure 3. Overall treatment strategy for peripheral arterial disease. BP, blood pressure; HbA1c, 
hemoglobin A1c; LDL, low density lipoprotein; MRA, magnetic resonance angiography; CTA, 
computed tomographic angiography. (Modified from Hiatt WR. N Engl J Med 2001;344:1608 
1621.) 
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In a study by Currie et al., successful endovascular treatment of claudication compared to  
unsupervised exercise results in a significant improvement in the patient's quality of life (QoL) in 
the domains of physical functioning (p < 0.001), physical role (p < 0.005), pain (p < 0.001) and 
vitality (p < 0.05) after 3 months’ follow-up (Currie et al., 1995). However, to achieve this, the 
arterial lesion behind the symptoms must be suitable for endovascular treatment. In the study of 
Chetter et al., endovascular treatment resulted an immediate and lasting improvement in the QoL of 
claudicants, with unilateral claudicants with a solitary iliac lesion demonstrating the most marked 
QoL benefit during a 12-month follow-up (Chetter et al., 1998).  However, infrapopliteal 
endovascular procedures are recommended only if patients have CLI, but not in claudication 
(Norgren et al., 2007). Endovascular techniques must be safe and focused on those likely to obtain 
long-term benefit, and they must be opted for after an attempt at non-invasive treatment.  
 
The question whether endovascular or surgical revascularisation is the best method of the treatment 
of CLI is controversial. At present, there is only one multi-centre randomised controlled trial, the 
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) (Adam et al., 2005), comparing 
these two different treatments. The published results of the BASIL trial indicate that patients 
presenting with severe limb ischemia due to infrainguinal atherosclerosis who seem technically 
suitable for both treatments can reasonably be treated with either method. In the BASIL  trial, the 
scope of generalisation of the study was audited. During the 6-month BASIL audit, 585 consecutive 
patients presented with severe limb ischemia and underwent diagnostic imaging. Of these, 129 
(22%) needed supra-inguinal intervention and were not candidates for the trial. Of the remaining 
456 patients, 220 (48%) were treated without revascularization and 236 (52%) underwent 
revascularization. Only 70 (30%) of the 236 patients with severe limb ischemia were regarded as 
suitable for randomisation into BASIL, and of these, 22 (31%) refused trial entry – the remaining 48 
(69%) were randomised, being suitable for both treatment methods (Adam et al., 2005). The 
 32
medium-term outcomes after angioplasty and surgery in BASIL were broadly similar with respect 
to amputation-free survival, all-cause mortality and health-related quality of life. In the short term, 
the surgically treated were associated with a significantly higher rate of morbidity, longer hospital 
stays and greater use of the high-dependency unit and intensive therapy unit than those treated with 
angioplasty. Therefore, hospital costs of surgery for the first 12 months were approximately one 
third higher than those of angioplasty. In the long term, after 2 years, surgery seemed to be 
associated with a significantly reduced risk of future amputation, improved durability and reduced 
re-intervention rate, which implicated that surgery could outweigh the short-term considerations of 
increased morbidity and cost.(Adam et al., 2005). 
 
Based on BASIL, with due consideration to the poor generalizability of the trial, the high failure 
and re-intervention rate associated with angioplasty leads to the conclusion that patients who are 
expected to live less than 1–2 years and have significant co-morbidities should probably be offered 
angioplasty as a first-line treatment. By contrast, in patients expected to live more than 2 years who 
are relatively fit, the apparent improved durability and reduced re-intervention rate of bypass 
surgery seem to favour surgery (Adam et al., 2005). 
 
1.6 Risk stratification in CLI 
 
The prognosis of a patient with CLI is extremely poor. The natural history of patients with CLI is 
impossible to describe, because the majority of these patients receive some form of active treatment. 
Large surveys suggest that approximately half of CLI patients will undergo some type of 
revascularisation, roughly a quarter receive medical treatment only, and the rest will require a 
primary amputation. After one year, only some 25% of the patients are still alive with their leg and 
CLI resolved, and because of general atherosclerosis, the majority of the morbidity and mortality 
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derives from cardiovascular reasons, including major limb loss, myocardial infarction, stroke and 
death (Lepantalo and Matzke, 1996)(Norgren et al., 2007)(Adam et al., 2005)(Figure 4).  Therefore, 
in order to deem a revascularisation procedure a successful and worthwhile endeavour, there should 
be a reasonable probability that the patient will remain alive for one year with the treated limb 
(Second european consensus document on chronic critical leg ischemia. 1992). Otherwise, 
alternative therapies including conservative care or primary amputation should be strongly 
considered.  
 
 
 
 
Figure 4. Survival of patients with peripheral arterial disease. IC, intermittent claudication; CLI, 
critical limb ischemia. (Modified from TASC working group 2007.) 
 
1.6.1 Risk assessment of patients undergoing major non-cardiac surgery 
 
The purpose of preoperative risk assessment of patients undergoing major surgery is to identify 
patients at increased risk for perioperative mortality and morbidity. Since perioperative cardiac 
mortality and morbidity are the most frequently occurring adverse events in major non-cardiac 
surgery and vascular surgery, most developed risk indexes (Lee index (Kertai et al., 2005), Eagle 
score(Eagle et al., 1989b), Vanzetto score (Vanzetto et al., 1996)(Kertai et al., 2005)) have focused 
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on the evaluation of perioperative cardiac risk, and vascular surgery patients are well-identified as 
high cardiac risk patients (Eagle et al., 1996).  
 
The American Society of Anesthesiologists classification (ASA) (1963) has received wide 
acceptance, but it is used to evaluate the physical status of the patient preoperatively and is not 
intended for use as a risk adjustment tool (Wolters et al., 2006). A good correlation between 
mortality and the ASA has been established (Hall and Hall, 1996)(Wolters et al., 1997), as well as a 
correlation with respect to morbidity (Wolters et al., 1997). In a prospective study on a group of 
PAD patients receiving an aorto-bi-iliac or aorto-bifemoral bypass, Wolters et al. noted that a 
majority of the patients were classified in ASA II (23%) and ASA III (73%), with only 4% in ASA 
IV and none in ASA classes I and V(Wolters et al., 2006). The higher the ASA score, the older 
were the patients, and the authors found no significant correlation between ASA classification and 
postoperative mortality or morbidity. The ASA classification is therefore problematic in predicting 
the fate of an individual patient, and its usefulness in that respect is limited. 
 
The Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity 
(POSSUM) risk-adjusted scoring system for predicting mortality in surgical patients was originally 
developed by Copeland et al. (Copeland, Jones and Walters, 1991) as a surgical audit scoring 
system between various hospitals. The mortality risk is predicted using a 12-factor, 4-grade 
physiological score (PS) and a 6-factor, 4-grade operative score (OS). The original POSSUM 
mortality regression equation has been modified by the Vascular Surgical Society of Great Britain 
and Ireland to produce a regression equation (V-POSSUM) that can be specifically applied to 
patients undergoing major vascular surgery (Copeland et al., 1993). The POSSUM score has been 
used to score patients with abdominal aortic aneurysm (AAA) repairs in both elective (Prytherch, 
Sutton and Boyle, 2001)(Shuhaiber et al., 2001) and ruptured cases (Jones, 1991, Lazarides et al., 
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1997). In the study by Volters et al. (Wolters et al., 2006)(Wolters et al., 2006), the POSSUM 
scoring was contradictory to the mortality observed, and the regression analysis in this respect did 
not turn out to be a significant predictor of postoperative mortality or morbidity. On the other hand, 
Mosquera et al. (Mosquera, Chiang and Gibberd, 2008) found a trend toward lowered risk-adjusted 
predicted mortality using V-POSSUM, but this benefit came from the general performance of 
surgery and did not predict the fate of individual patients. 
 
There are a number of different indexes used as a means to evaluate surgical risks but which were 
originally planned for postoperative intensive care unit patients (APACHE (Knaus et al., 1981) 
SAPS (Le Gall, Loirat and Alperovitch, 1983). In vascular surgery, the focus of risk evaluations has 
been on AAA procedures, and the previously mentioned risk scoring systems have been used to 
estimate operative risk and predict outcome. Because of their complexity and the fact that they have 
not been developed for that purpose, there has been a need to find a model that is easy to calculate 
and use. Samy et al. (Samy, Murray and MacBain, 1994, Samy, Murray and MacBain, 1996) 
derived and validated a simple scale, the Glasgow Aneurysm Score (GAS), for risk stratification of 
patients undergoing elective and emergency open repair of AAA. It identified preoperative shock, 
myocardial dysfunction, renal impairment and cerebrovascular disease as significant factors in 
determining postoperative outcome (Samy, Murray and MacBain, 1994). In further studies by 
Biancari et al. (2003), the model was validated using data on 403 patients operated in a single 
hospital and again using the Finnvasc national database (Biancari et al., 2003, Biancari et al., 2003). 
In a systematic review of the current evidence predicting risk in elective AAA repair, Patterson et 
al. (Patterson et al., 2008) estimated GAS to be the most useful and consistently validated risk 
scoring system at present for risk prediction in open AAA repair. Drawbacks of the GAS are that it 
does not reliably identify individual high-risk patients due to a low positive predictive value 
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(Biancari, Hobo and Juvonen, 2006) and that it is consistently inaccurate when used to predict 
morbidity (Patterson et al., 2008). 
 
1.6.2 Risk assessment in CLI 
 
Since perioperative cardiac mortality and morbidity are the most frequently occurring adverse 
events in non-cardiac vascular surgery, the majority of the previously-mentioned risk indexes are 
focused on the evaluation of perioperative cardiac risk (Kertai et al., 2005, Eagle et al., 1989b). 
However, there is a strong relationship between perioperative cardiac and non-cardiac 
complications and subsequent mortality; almost half of the patients who experience cardiac 
morbidity develop other types on non-cardiac complications and mortality (Fleischmann et al., 
2003). In addition, the currently available risk indexes estimate the risk of cardiac death rather than 
all-cause mortality, which may lead to inappropriate interpretations and underestimation of the 
factors increasing the risk of all-cause mortality (Kertai et al., 2005, Lauer et al., 1999).  
 
1.6.3 The PIII risk score 
 
Schanzer et al. (Schanzer et al., 2008) presented the PIII risk score model to predict amputation-free 
survival (AFS) using multi-centre data on surgical outcomes. The model included five independent 
predictors identified from the Project of Ex-Vivo graft Engineering via Transfection III (PREVENT 
III) database (Conte et al., 2006): dialysis-dependent renal failure (4 points), tissue loss defined as a 
non-healing ulcer or gangrene (3 points), advanced patient age ≥ 75 years (2 points), anaemia 
(hematocrit < 30, 2 points) and CHD (1 point) (Figure 5). The PIII risk score is meant to be a 
clinical tool for surgical decision-making, enabling physicians to generate a preoperative risk 
estimate that addresses an individual patient's likelihood of success or failure after surgical 
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revascularisation. The PIII estimates amputation-free survival and does not predict mortality and 
morbidity. In the validation by Schanzer et al.(Schanzer et al., 2009), the PIII risk score was tested 
against 3,285 CLI patients who underwent a infrainguinal autogenous vein bypass in a multicentre 
study. PIII seemed to be a simple and reliable method to risk stratify CLI patients being considered 
for bypass into three distinct categories of expected amputation free-survival. (Schanzer et al., 
2009). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. PIII risk score card for CLI. (Modified from Shanzer 2008).  
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1.6.4 The Lee index and Customised Probability Model  
 
The Customised Probability Model (CPM) presented by Kertai et al. (Kertai et al., 2005) estimates 
the risk of perioperative all-cause mortality. The model is a modification of the Lee index (Lee et 
al., 1999b) and meant to serve as a predictor of cardiac complications and perioperative all-cause 
mortality for patients undergoing vascular surgery. The model includes five of the six predictors 
from the original Lee index (high-risk type of surgery, ischemic heart disease, congestive heart 
failure, cerebrovascular disease and renal dysfunction) associated with an increased risk of 
perioperative all-cause mortality. However, the risk associated with the type of elective vascular 
surgery as defined by the Lee index only differentiates high-risk procedures (abdominal aortic 
surgery) and low-risk procedures (infrainguinal bypass, carotid endarterectomy and aortobifemoral 
bypass). In CPM the type of surgery is redefined on the basis of timing (acute or elective), 
complexity and reported mortality rates, and the type of vascular surgery procedure is considered an 
important predictor of mortality (Kertai et al., 2005). CPM is the only model to pay attention to 
medication: If the patient has any of the risk factors described in CPM, β-blockers should be 
incorporated into the perioperative risk-reduction strategies (Boersma et al., 2001). Patients 
identified by clinical risk factors and non-invasive testing as being at high risk are often susceptible 
to considerable perioperative mortality despite β-blocker use (Boersma et al., 2001), and for these 
patients a combination of β-blockers and statins may offer additional prevention (Poldermans et al., 
2003). Therefore, the CPM considers both β-blockers and statins in the risk score, suggesting that if, 
despite medication, the estimated probability of death remains high and there is a clear indication 
for coronary revascularisation independent of the need for vascular surgery, a coronary intervention 
should be considered (Kertai et al., 2005, Eagle et al., 2002). The role of β-blockers is controversial: 
in a systematic review and meta-analysis, Wiesbauer et al. showed that β-blockers reduce 
perioperative arrhythmias and myocardial ischemia but had no effect on myocardial infarction, 
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mortality or the length of hospitalization(Wiesbauer et al., 2007). In a recent meta-analysis by Talati 
et al., β-blockers seemed to have a trade-off between a reduction in myocardial infarction and an 
increase in stroke, thus producing a troubling trend towards an increase in mortality (Talati et al., 
2009). 
 
1.6.5 The Finnvasc risk-scoring method 
 
In a large study based on the Finnvasc registry (Salenius, 1992), independent predictors for 30-day 
postoperative mortality and major amputation were analyzed from the data on 3,925 infrainguinal 
surgical revascularisation procedures (Biancari et al., 2007). In this model diabetes, CHD, foot 
gangrene and urgent operation were risk factors that yielded 1 point each in the score. The 30-day 
postoperative mortality / major lower limb amputation rate increased significantly along with this 
additive risk score, as did also occur for the 30-day postoperative mortality and major lower limb 
amputation rates (Biancari et al., 2007). In this simple scoring method based on well-known risk 
factors, patients with three points had significantly higher postoperative mortality and/or limb loss. 
Recently, the scoring method has been validated with prospective data on 512 infrainguinal PTA 
revascularization procedures for CLI, and the method seemed to be useful in estimating the risk of 
immediate post-procedural mortality and/or major lower limb amputation also in patients 
undergoing infrainguinal PTA for CLI (Kechagias et al., 2008). 
 
1.7 Invasive treatment of PAD and quality of life 
 
Although the success of a particular intervention has traditionally been described in terms of graft 
patency and limb salvage, the primary goal for revascularisation procedures in the treatment of 
PAD is to improve the patient’s quality of life. However, published data seldom provide 
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information on the ultimate effect of interventions on patients' quality of life. The TransAtlantic 
Inter-Society Consensus (Norgren et al., 2007) recommended that QoL instruments should be used 
in all clinical trials, but at present there is no established disease-specific questionnaire for QoL 
assessment for patients with CLI. The changes in ABI and walking distance are the basics values of 
postoperative evaluation for revascularisation procedure success, but they have proven to have 
relatively weak correlation with QoL (Currie et al., 1995, Whyman et al., 1996).   
 
Two types of instruments are available to measure QoL: disease-specific and generic (Anderson, 
Aaronson and Wilkin, 1993). Generic instruments such as the Nottingham Health Profile (NHP) 
(Hunt and McEwen, 1980), the Short-Form 36 Health Survey (SF-36) (Ware and Sherbourne, 1992) 
and 15D (Sintonen, 1994) are applicable to a wide variety of populations. They address 
multidimensional aspects – such as physical functioning, emotion or mood, social functioning, role 
performance, pain and commonly performed daily activities (Klevsgard et al., 2002) – and have 
been used for and proven to have an acceptable degree of reliability in group-level comparisons. 
The NHP, however, seems to be better in discriminating the severity of ischemia and is thus more 
responsive in patients with CLI (Wann-Hansson et al., 2004). Disease-specific instruments such as 
the VASCUQOL (Vascular Quality of Life Questionnaire) (Morgan et al., 2001) and Intermittent 
Claudication Questionnaire (ICQ) (Chong et al., 2002) have been developed for claudication 
patients, including specific parameters related to overall symptoms and management in treadmill 
testing connected with ABI measurements.  
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2 AIMS OF THE STUDY 
 
The aims of the present study were to investigate the risk factors of operative treatment and the 
impact of endovascular treatment of chronic lower limb ischemia in CLI. Furthermore, the devise 
models for identifying high-risk patients to minimise procedure-dependent mortality and morbidity 
were examined. The specific questions were: 
 
1.  Are there any differences in the grade and location of arterial stenosis between 
diabetics and non-diabetics with PAD? 
 
2. What is the role of DM as a risk factor for surgery on CLI? 
 
3.  What is the impact of endovascular treatment of claudication and CLI on the quality 
of life? 
 
4.  Could GAS predict survival in surgical treatment of CLI? 
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3 PATIENTS AND METHODS 
  
3.1 Does diabetes protect the femoral artery against atherosclerosis? (Study I) 
 
The study group consisted of 60 non-diabetic and 38 diabetic patients with lower extremity disease 
and no previous vascular interventions. Patients were collected to the study in a prospective manner 
at the Central Hospital of Central Finland between November 1999 and September 2000. The 
patients were referred to the hospital because of suspected circulatory problems in their lower 
extremities. The anamnesis and the reason for hospitalisation were recorded. The patients were 
evaluated by measuring walking distance on a treadmill and the ankle-brachial index (ABI). Arterial 
lesions were investigated by digital subtraction angiography (DSA).  
 
Each examination was subsequently evaluated by one experienced angiologist who had no previous 
information as to whether a patient was diabetic or non-diabetic. The scoring system used was 
modified from an article by Faglia et al. (Faglia et al., 2007). The extent of the stenosis in each 
vessel segment was determined visually and displayed numerically. The highest lumen reduction in 
each segment determined the score for the segment. This was 0 if the lumen was reduced to 50% or 
less at its narrowest point, 1 if the reduction was 50%–75%, 2 if the reduction was 76%–99% and 3 
if there was a total occlusion. In the foot the score was 0 if there was at least one arterial trunk (i.e. 
dorsal or plantar artery) patent, and 1 if both were invisible. 
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3.2 Diabetes as an independent risk factor for early postoperative complications in critical limb 
ischemia (Study II) 
 
Data on all vascular procedures performed in Finland during 1991–1999 were systematically 
collected into the national Finnvasc registry. All five university hospitals, all of the 16 central 
hospitals and the four largest district hospitals participated in the registry. The details of the 
Finnvasc protocol have been described elsewhere (Salenius, 1992). The protocol consisted of 
preoperative patient data such as risk factors and the indication for surgery, in addition to operative 
details such as urgency, procedure code and anatomy, graft, as well as data concerning the 30-day 
outcome including postoperative complications, re-operations and patency data. All arterial surgery, 
including endovascular interventions and access surgeries, were entered in the registry. One 
vascular surgeon in each hospital was responsible for data collection and the validity of the data. At 
the hospitals, information was recorded in paper form and sent to the central office where data were 
entered on a computer. The data includes a total of almost 40,000 surgical and endovascular 
procedures.  
 
In the study, all 5,709 surgical procedures performed due to CLI were selected from the Finnvasc 
registry data. Critical ischemia was defined according to the Fontaine classification as F III or F IV, 
i.e. ischemic rest pain, non-healing ulcer or tissue defect or gangrene, irrespective of the distal 
ankle-brachial index (ABI) measured. Risk factors for perioperative death and morbidity were 
analysed with special emphasis on differences between diabetics and non-diabetics. 
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Logistic multiple regression was used to analyse the influence of factors affecting postoperative 30-
day outcome. The independent factors analysed are presented in Table 2 and the dependent (30-day 
outcome) factors that were tested in Table 3. 
 
In addition, analysis was carried out separately for both groups, the diabetics and non-diabetics, to 
find out if there were differences in the influence of various risk factors on 30-day mortality. The 
independent factors analysed were the same as in the analysis mentioned above, with diabetes as a 
discriminator. Of the 5,709 procedures, 2,508 were performed on diabetics (43.9%).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Independent factors. 
 
Age and sex  years, male/female 
   
Cardiac risk previously documented myocardial infarction and/or ongoing angina pectoris 
or previous coronary bypass surgery  
  
Diabetes   hyperglycaemia requiring diet, oral medication or insulin treatment 
 
Hypertension  medication for hypertension or arterial pressure >160/95 mmHg 
 
Cerebrovascular disease  history of stroke or transient ischemic attacks 
 
Pulmonary disease  asthma or chronic obstructive pulmonary disease 
 
Renal failure  creatinine > 150 umol/L 
 
Smoking   current smoker 
 
Indication for surgery  divided in three categories: rest pain, ulceration, gangrene 
 
Anatomic level and  divided in 5 main categories: aortoiliac or femoral reconstruction, 
extent of the procedure  extra-anatomic reconstruction for central PAD, femoral endarterectomy 
including profundoplasty, femoropopliteal reconstruction, femorodistal 
reconstruction 
 
Urgency of the  (elective, urgent) and whether the procedure was primary or secondary  
procedure    
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Table 3.The dependent (30-day outcome) factors.
Cardiac complication  myocardial infarction or ischemia with ECG changes (electrogardiogram)
and/or raised troponin levels
Cerebrovascular stroke or transient ischemic attack (TIA)
complication
Renal complication renal failure with raised serum creatinine level from 150 umol/l up to
irreversible renal insufficiency requiring dialysis
Respiratory pulmonary embolism, pneumonia or pulmonary oedema
complication
Superficial wound local wound infection which was cured with local care and antibiotics and did
infection not need revision or drainage in the operating room
Below-knee (BK) amputation
Above-knee (AK) amputation
Multi-organ failure (MOF)
Acute occlusion of the graft or endarterectomised segment after surgery
 46
3.3 Impact of endovascular treatment on clinical status and health-related quality of life (Study III) 
  
A total of 61 consecutive patients and 64 limbs underwent a primary PTA (percutaneous 
transluminal angioplasty) procedure in a teaching hospital of an academic institution during a 
period of 18 months. Data were collected prospectively. Clinical criteria for categories of chronic 
limb ischemia were outlined according to Ahn and Rutherford (Ahn et al., 1993). The clinical 
grades I (claudication), II (ischemic rest pain) and III (tissue loss) account for the different natural 
histories of each group. ABI was used as a non-invasive haemodynamic assessment together with 
triplex scan evaluation performed immediately and one year after the PTA procedure. The quality 
of life was assessed using the Nottingham Health Profile (NHP) developed by Hunt and McEwen 
(Hunt and McEwen, 1980), and its Finnish version was employed in this study (Koivukangas P, 
Ohinmaa A, Koivukangas 1995). The NHP is a two-part instrument, and only part I was used. The 
38 yes/no items reflect the patient's degree of distress within the domains of pain, physical mobility, 
emotional reactions, energy, social isolation and sleep. The answers are given as a score between 0 
and 100 describing the degree of harm in each item. The NHP questionnaire was filled out before 
the PTA procedure as well as one month and one year after the procedure.   
 
3.4 Predictors for the immediate and long-term outcome of a vascular surgical procedure (Study IV) 
  
The data consisted of 157 consecutive patients who underwent an elective vascular surgical 
procedure in a teaching hospital between April 2002 and April 2003. The preoperative examination 
and data collection were performed by a vascular surgeon or vascular surgical fellow, and the ASA 
score was determined by an anaesthetist. 
 
Patients were divided into three groups according to the indication for surgery: carotid, chronic limb 
ischaemia and abdominal aortic aneurysm procedures. The Glasgow Aneurysm Score (GAS) was 
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calculated using the following formula: age in years + 7 (for myocardial disease) + 10 (for 
cerebrovascular disease) + 14 (for renal disease)  (Samy, Murray and MacBain, 1994, Samy, 
Murray and MacBain, 1996). Myocardial disease refers to a previously documented myocardial 
infarction and/or ongoing angina pectoris. Cerebrovascular disease refers to all grades of stroke 
including TIA. Renal disease refers to a history of chronic and acute renal failure, and/or a serum 
creatinine level greater than 150 µmol/l at the time of surgery. Patients were divided into two GAS 
groups based on the study by Hirzalla et al. (Hirzalla et al., 2006): GAS <77 (GAS low) and 
GAS>=77 (GAS high).  
 
A postoperative renal complication was defined as an increase in the serum concentration of 
creatinine or urea requiring medical treatment or dialysis. A postoperative cardiac complication was 
defined as a myocardial infarction (ECG changes or increased serum troponin level) or death due to 
cardiac causes, as well as postoperative cerebrovascular complications such as a TIA or stroke. 
Long-term mortality data for up to 5 years postoperatively were obtained from Statistics Finland. 
 
3.5 Statistical methods 
 
In all original articles the data were statistically analyzed using SPSS (Statistical Package for Social 
Sciences) software, and in Study I the Kolmogrov-Smirnov test was used to test the normality of the 
distributions of the variables. Differences in the mean values of the variables between diabetics and 
non-diabetics were analyzed by means of the Mann-Whitney test. Associations between pairs of 
variables were studied using the Chi-squared test or Spearman's correlation.  
 
In Study II results were expressed as mean and standard deviation. Differences between means were 
tested for significance using two-tailed Student’s t-test. Comparison of proportions was performed 
 48
using Pearson’s 2 test or the Odds ratio. Multivariate analysis was performed using logistic 
regression. The p values less than 0.05 were considered significant.  
 
In Study III mean values of the variables between claudication and CLI patients were compared 
using the independent samples t-test or the Mann-Whitney test. The means of the preoperative, 30-
day follow-up and one-year follow-up values were compared using the dependent samples t-test or 
the Wilcoxon test and general linear models for repeated measures.  
 
In Study IV data was expressed as mean value and standard deviation. The Chi-Square test, logistic 
regression as well as the Cox proportional hazards model and the Kaplan-Meier Survival Analysis 
were used in data analysis.  
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4 RESULTS 
Table 4. Basic characteristics of the individual studies. 
 
 
*     11/1999 – 9/2000 Vascular Surgery Outpatient Clinic and Emergency Care Deparment of the Central Hospital of 
       Central Finland 
**   5/2002 – 1/2005 Vascular Surgery Outpatient Clinic of the Department of  Vascular Surgery, Tampere University 
       Hospital 
*** 4/2002 – 4/2003 Vascular Surgery Outpatient Clinic of the Department of Vascular Surgery, Tampere University 
       Hospital 
 
 
Study I II III IV 
 
Subjects / 
Number of 
participants 
 
98 consecutive 
patients * 
 
Finnvasc, national 
registry: 5,709  CLI 
patients 
 
61 consecutive 
patients ** 
 
157 consecutive 
patients*** 
Design Prospective clinical 
study 
Retrospective 
registry-based study 
 
Prospective clinical 
study 
Prospective clinical 
study 
Aim of study Investigation of the 
extent of 
atherosclerotic 
stenoses in different 
segments of the leg 
arteries  
Evaluation of 
diabetes as a risk 
factor for post-
operative major 
morbidity and 
mortality after 
surgery for CLI 
 
Investigation on the 
impact of PTA on 
clinical status and 
health-related 
quality of life with 
claudication and 
CLI 
Investigation of the 
risk factors for 
short- and long-term 
outcome after 
vascular surgical 
procedures 
 
 
Methods Scoring of arterial 
lesions on DSA 
Multivariate analysis 
of preoperative risk 
factors 
Clinical status: 
Fontaine 
classification and 
ABI 
Quality of life: NHP 
Outcome after 
procedure: Triplex 
scan evaluation  
 
GAS predicting 
short- and long-term 
outcome 
 
 
Results / 
Conclusions 
Diabetics had fewer 
stenoses in the 
superficial femoral 
artery 
 
Diabetics had a 
tendency towards 
more diffuse 
atherosclerotic 
disease in crural 
arteries  
Diabetes was not an 
independent risk 
factor for early post-
operative mortality 
in CLI, as there was 
increased morbidity 
in diabetics 
associated with 
definitive risk 
factors 
In claudication PTA 
resulted in an 
immediate 
improvement in the 
quality of life, but 
this effect seems to 
vanish in the long 
term.  
 
There was a 
subgroup of CLI 
patients in whom 
PTA led to a 
significant benefit in 
terms of limb 
salvage and quality 
of life 
GAS had good 
predictive value for 
outcome after 
general vascular 
surgical procedures 
among low-risk 
patients (GAS < 77) 
 
For high-risk 
patients, due to its 
low predictive value 
for death, GAS 
yields limited value 
in clinical practice 
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4.1 Anatomical findings between diabetics and non-diabetics  
 
Diabetics were referred to hospital because of more severe symptoms (foot ulcers or ischemic rest 
pain) than non-diabetics whose most usual reason for referral was claudication (Table 5).  Walking 
distance ranged from 17 to 500 meters, with a mean value of 230 meters, and 28 patients were not 
able to take a treadmill test. Of these 28, 11 patients had substantial ulcers in the foot and five 
suffered from severe rest pain and not being able to walk. Furthermore, three patients had 
hemiplegic symptoms after a cerebral stroke and nine suffered from general weakness due to old 
age. ABI ranged from 0.23 to 1.01, with a mean of 0.62. In 21 cases, ABI had not been evaluated 
either because the patients had arrived in hospital from the emergency department or ABI could not 
been defined because of incompressible arteries. 
 
 
  Diabetes 
Symptom (N/%) No Yes Total 
 
Claudication        47 (78.0) 13 (34.2) 60 (61.2) 
Ulcers  6 (10.0) 12 (31.6) 18 (18.4) 
Rest pain  4 (6.7) 9 (23.7) 13 (7.1) 
Other*  3 (5.0) 4 (10.5) 7 (7.1) 
*Cold feet 
   swelling 
   skin pigmentation 
   suspected failure in circulation 
 
Table 5. Reason for referral for further examinations. 
 
In the scoring analysis, statistically significantly fewer (score value 1,55 vs. 1,00 P=0,037) stenoses 
were found in the superficial femoral artery in diabetics than in non-diabetics. Although a tendency 
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towards more diffuse changes in crural arteries was found, no statistically significant differences 
were observed in other segments of the lower leg arteries apart from the femoral arteries. At the 
aorto-iliac level, there were no significant differences between patient groups.  
 
4.2 Risk factors and survival from the procedures 
 
The early (30-day) complications in diabetics and non-diabetics after surgery for CLI are presented 
in Table 6, the multivariate analysis of the risk factors for early postoperative death in Table 7, and 
adjusted odds ratios with a 95% CI from multiple logistic regression for postoperative 
complications in a 30-day follow-up in diabetics and non-diabetics in Figure 6. 
 
In multivariate analysis, aortofemoral reconstruction (OR, 4.0), preoperative cardiac risk factor 
(OR, 3.1), primary surgery (OR, 2.0), renal insufficiency (OR, 1.9), urgent surgery (OR, 1.7), and 
age (OR, 1.3) were found to be independent factors for postoperative death, whereas diabetes was 
not an independent risk factor for 30-day mortality after the procedure (OR, 1.3; 95% confidence 
interval [CI], 0.95-1.75; P=0.8) (Table 8). 
 
In multivariate analysis of the 30-day follow-up for diabetics compared to non-diabetics, diabetes 
was found to be an independent risk factor for postoperative BK amputation (OR, 1.7), cardiac 
complications (OR, 1.5), and superficial wound infection (OR, 1.3) (Figure 6).   
 
Multivariate analysis was also used to evaluate whether there were differences in the predictive 
value of various pre- and intra-operative factors on 30-day outcome between diabetics and non-
diabetics. Aortofemoral reconstruction (OR 2.5), urgent surgery (OR 2.0), male sex (OR 2.0), renal 
insufficiency (OR 1.9), cardiac risk factor (OR 1.7) and age (OR 1.4) were independent risk factors 
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for early postoperative mortality in diabetics. In non-diabetics, independent risk factors for early 
postoperative mortality were aorto-iliac or aorto-femoral reconstruction (OR 4.5), cardiac risk 
factor (OR 3.6), primary surgery (OR 2.6) and extra-anatomic bypass for central peripheral arterial 
occlusive disease (OR 2.3) (Table 8). 
    
        
          
                   Total         Diabetics     Non-diabetics P-value 
   n % n % n %   
Superficial wound infection 731 12.8 395 15.7 336 10.5 <0.001 
Below-knee amputation  270 4.7 164 6.5 106 3.3 <0.001 
Cardiac complication  401 7.0 221 8.8 180 5.6 <0.001 
Cerebrovascular complication 94 1.6 53 2.1 41 1.3 <0.05 
Renal complication  70 1.2 40 1.6 30 0.9 <0.05 
Death   221 3.9 111 4.5 110 3.4 =0.05 
Acute graft occlusion  561 9.8 230 9.2 331 10.3 n.s. 
Respiratory complication  171 3.0 69 2.8 102 3.2 n.s. 
Above knee amputation  194 3.4 87 3.5 107 3.3 n.s. 
MOF     24 0.4 10 0.4 14 0.4 n.s. 
          
n.s. = nonsignificant         
          
Table 6. Early (30-day) complications in diabetics and non-diabetics after surgery for critical limb ischemia. 
   
       
        
        OR   95% CI   
Aortoiliac or -femoral reconstruction¹  4.0 ** (2.5-6.4)   
Cardiac risk    3.1 ** (2.3-4.4)  
Primary compared to secondary surgery  2,0 * (1.3-3.1)  
Renal insufficiency   1.9 * (1.2-2.9)  
Extra-anatomic bypass for central PAOD¹  1.8 * (1.2-2.9)  
Urgent compared to elective surgery  1.7 ** (1.3-2.4)  
Age (per 10 years)   1.3 ** (1.1-1.4)  
Diabetes    1.3  (0.95-1.7)  
Male sex   1.3  (0.9-1.7)  
Gangrene compared to rest pain  1.3  (0.8-2.0)  
Cerebrovascular risk   1.2  (0.8-1.7)  
Pulmonary risk   1.2  (0.8-1.8)  
Femorodistal reconstruction¹   1.2  (0.8-1.9)  
Ulcer compared to rest pain   1.1  (0.8-1.6)  
Femoral endarterectomy¹   1.0  (0.5-1.8)  
Smoking    0.9  (0.6-1.3)  
Hypertension     0.8   (0.6-1.1)   
        
1 Compared to femoropopliteal reconstruction       
*P<.05        
**P≤.001 
        
Table 7. Multivariate analysis of the risk factors for early (30-day) postoperative death.
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Table 8. Multivariate analysis of the significance of preoperative factors for early (30-day) postoperative  
mortality in diabetics and non-diabetics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
       
        
                          Diabetics                      Non-diabetics  
                  RR   (95% CI)   RR  (95% CI)  
Aortoiliac or -femoral reconstruction 1 2.5 * (1.1-5.9) 4.5 ** (2.4-8.3)  
Urgent compared to elective surgery  2.0 * (1.3-3.2) 1.4  (0.9-2.3)  
Male sex  2.0 * (1.3-3.0) 0.8  (0.5-1.3)  
Renal insufficiency  1.9 * (1.1-3.3) 1.9  (0.9-4.1)  
Cardiac risk  1.7 ** (1.4-2.2) 3.6 ** (2.3-5.6)  
Age (per 10 years)  1.4 ** (1.2-1.7)  1.0  (0.7-1.2)  
Femoral endarterectomy 1 1.7  (0.8-3.6) 0.4  (0.1-1.4)  
Primary compared to secondary surgery  1.5  (0.8-2.7) 2.6 * (1.3-5.2)  
Pulmonal insufficiency  1.4  (0.8-2.6) 1.1  (0.7-1.9)  
Femorodistal reconstruction 1 1.4  (0.8-2.3) 1.0  (0.5-1.9)  
Gangrene compared to rest pain  1.2  (0.7-2.2) 1.2  (0.6-2.5)  
Ulcer compared to rest pain  1.1  (0.7-1.9) 1.2  (0.8-1.8)  
Extra-anatomic bypass for central PAOD 1 1.1  (0.6-2.4) 2.3 * (1.3-4.2)  
Hypertension  1.0  (0.7-1.5) 0.7  (0.5-1.1)  
Smoking  1.0  (0.5-1.7) 0.9  (0.6-1.4)  
Cerebrovascular disease   1.0   (0.8-1.3) 1.4   (0.9-2.4)  
1 Compared to femoropoplitel reconstruction        
*P<.05        
**P<.001        
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Figure 6. Adjusted Odds ratios with 95% CI from multiple logistic regression1 for postoperative complications2 in 30-
day follow-up in diabetics compared to nondiabetics. 
 
 
 
 
 
  
                            
                     1.7           
BK amputation                                  P<.001   
                   1.5             
Cardiac                            P<.001       
                 1.3               
Superficial infection                    P<.001          
                   1.6            
Renal                                        P=.11    
                  1.4              
Cerebrovascular                                    P=.12     
                 1.2                
Respiratory                           P=.38          
                 1.1                 
AK amputation                      P=.54            
            0.9                    
MOF                                       P=.73      
                              
Acute occlusion            P< .01                    
                                                    
      0.4   0.6   0.8   1.0   1.2   1.4   1.6   1.8   2.0   2.2   2.4   2.6  
                            
BK=Below knee                          
AK=Above knee                          
MOF=Multi organ failure                       
                            
1 Factors that were evaluated in the logistic regression analysis:           
                            
 Age                         
 Sex                        
 Diabetes        Hyperglycemia requiring diet, oral medication or insulin treatment 
 Hypertension      Medication for hypertension or arterial pressure >160/95 mmHg 
 Cardiac risk factor     Previously documented myocardial infarction and/or ongoing  
            angina pectoris or previous coronary artery bypass surgery  
 Cerebrovascular risk factor   History of stroke or transient ischemic attacks     
 Pulmonal risk factor     Asthma or chronic obstructive pulmonary disease    
 Renal risk factor      History of chronic and acute renal failure, and/or serum level of urea over 20  
            mmol/l and/or creatinine serum level greater than 150 micromol/l 
 Smoking        Current smoker or smoking during the previous 5 years   
 Preoperative severity of ischemia Rest pain vs. ulcer vs. gangrena         
 Anatomic level of reconstruction                  
  and extent of operation   Femoropopliteal reconstruction vs. femoral endarterectomy vs.  
            distal reconstruction vs. extra-anatomic reconstruction for  
            aortoiliac occlusion vs. aortoiliac-aortofemoral reconstruction 
 Urgency of the reconstruction  Elective vs. emergency operation        
 Primary vs. secondary procedure                  
                            
2 Postoperative adverse events                   
                            
 BK amputation      Below-knee amputation          
 Cardiac        EKG changes and/ or elevated troponin levels     
 Renal        Renal failure with raised serum creatinine level from 120 mmol/l  
            up to irreversible renal insufficiency requiring dialysis   
 Superficial infection     Local wound infection which cured with local care     
            and antibiotics, and which did not need revision or drainage in  
            operating room            
 Cerebrovascular      Stroke or TIA             
 Respiratory       Pulmonal embolism, pneumonia or pulmonal edema    
 AK amputation      Above knee amputation          
 MOF        Multiorgan failure            
 
Death 
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4.3 Impact of endovascular treatment on clinical status and health-related quality of life 
 
4.3.1 Claudication 
 
All limbs underwent triplex ultrasound immediately after the PTA, and 20/30 (66.7%) of the treated 
areas were open with 0%–50% residual stenosis, with 10 limbs having residual stenosis of 51%–
99%. None of the 30 segments treated were occluded. All patients were invited to and 26 attended a 
30-day clinical follow-up. At 30 days, 22/26 (84.6%) of the patients with a total of 27 treated limbs 
had no claudication, and 3/26 (11.5%) had claudication. The mean ABI in patients who underwent 
30-day follow-up increased from the preoperative 0.63 to 0.84. One patient who did not attend  the 
30-day control but did attend the one-year control with no claudication, the treated segment open 
with 0%–50% restenosis and an ABI of 1.02 in the treated limb. A total of 24 patients and 27 
treated limbs underwent the one-year follow-up, including a clinical control visit and triplex  
ultrasound: 21/24 (87.5%) had no claudication, and 3/24 (12.5%) had claudication which had been 
present throughout the one-year follow-up period. Triplex ultrasound showed that 17/27 (63.0%) 
controlled sections were open with 0%–50% restenosis, 9/27 (33.3%) were observed to have 51% –
99% restenosis, and 1/27 (3.7%) PTA segment was occluded. The mean ABI in these patients was 
0.63 preoperatively and 0.85 at one year's follow-up. Three patients did not attend the control 
examination: one was in very poor general condition and did not wish to attend the follow-up, and 
two did not come to the one-year control visit despite several calls, the reason for which remained 
unknown.  
 
4.3.2 Critical limb ischemia 
 
All patients underwent triplex ultrasound one day after the PTA – 13/34 (38.2%) segments were 
open with residual stenosis of 0%–50%, in 20/34 (58.8%) there was residual stenosis of 51%–99%, 
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and one of the treated sections occluded immediately. Twenty-seven of the 34 patients underwent a 
30-day clinical follow-up. At 30 days, 6/34 (18.6%) patients were asymptomatic, 9/34 (26.5%) had 
claudication, one (2.9%) suffered from rest pain, and 11/34 (32.4%) had a persisting ulceration. The 
mean ABI in patients who underwent the 30-day follow-up increased from 0.54 to 0.67. 
 
Thirteen patients underwent the one-year follow-up including a clinical control visit and a triplex- 
ultrasound examination. None of them suffered from critical limb ischemia at that time: eight 
patients were asymptomatic and five had claudication. At the one-year triplex ultrasound control, 
six patients had restenosis of 0%–50% in the PTA-treated arterial segment, and seven had 51%–
99% restenosis. No occlusions were observed. Among the 13 patients who underwent the one-year 
follow-up, ABI had increased from the preoperative 0.56 to 0.86 at one year's follow-up. Twenty-
one patients did not attend the one-year follow up: seven patients had died, six underwent 
amputation, and bypass surgery was performed on five patients. Three patients did not observe the 
invitation to attend the control examination, one of whom was in institutional health care and in 
very poor conditions at the time and for two patients the reason for not attending remained 
unresolved.  
 
4.3.3 Quality of life 
 
The quality of life was measured preoperatively, at 30 days' follow-up and at one year's follow-up. 
There were only 14 claudicants and 7 CLI patients who answered the questions on all occasions. In 
the domains of energy and pain, claudicants seemed to improve their value after one month, but 
these changes were not quite statistically significant, and at one year's follow-up, the scores were 
significantly worse than at one month's follow-up. For both claudicants and CLI patients, the mean 
value for energy was even worse at one year's follow-up than preoperatively, but the difference is 
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not statistically significant. For CLI patients, improvement was seen in the domain of pain, which 
continued at both follow-up points, and the difference was statistically significant between the one-
year follow-up and the preoperative score. In the domain of sleep, there was significant 
improvement for claudicants at one month's follow-up, and it continued until the one-year follow-
up was concluded. For CLI patients, the improvement was not so clear, but they also reported 
improved values at one year's follow-up in comparison to the preoperative score. Among 
claudicants, the domain of physical mobility was significantly improved at the one-month point 
when compared to the preoperative value, but at the one-year follow-up, the improvement had 
nearly disappeared and the score was no longer significantly better than preoperatively. 
 
4.4 Predictors for the immediate and long-term outcome of a vascular surgical procedure 
 
The most common indication for the procedure was chronic limb ischemia (61.5%, 95/157), 
followed by carotid disease (26.1%, 41/157) and abdominal aortic aneurysm (13.4%, 21/157).  
 
The 30-day mortality rate was 2.5% (4/157). The only independent risk factor for 30-day mortality 
was the renal risk factor (OR 20.2). None of the patients in the GAS low group died, and the 
mortality rate in the GAS high group was 10.7% (p=0.03). 
 
During the 5-year period following the procedure, 40.8% (64/157) of the patients died. In the Cox 
proportional hazards model, independent predictors for long-term mortality included the renal risk 
factor (OR 3.9), the cardiac risk factor (OR 2.3), age (OR 1.5) and procedure type (carotid surgery 
as a reference category: OR for an infrainguinal procedure 3.5 and for infrarenal aorta 3.3). Twelve-
month survival for the patients in the GAS low and GAS high groups was 98.6% and 78.6%, 
respectively (p<0.0001), the respective 5-year figures being 76.7% and 44.0% (p=0.0001). All four 
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patients with renal disease, cardiac disease and cerebrovascular disease died within 2 years of the 
procedure.  
 
5 DISCUSSION 
 
5.1 Distribution of atherosclerotic lesions in patients with PAD 
 
The early angiography-based studies carried out in the 1960s (Haimovici, 1967)(Conrad, 1967) 
already disclosed that the atherosclerotic process may exhibit a great variety of lesions in the lower 
extremities. However, a study by Strandness et al. (Strandness, Priest and Gibbons, 1964) reported 
that the pattern of occlusive involvement of the major arteries is distinctly different in diabetic than 
in non-diabetic patients, the former having a higher incidence of involvement in the arteries below 
the knee, and the incidence of involvement in the femoro-popliteal level is the same as for non-
diabetics. The concept of a more distal distribution of atherosclerotic occlusions in diabetic patients 
dates back to these early studies which did not report the incidence and severity of plaques and 
stenoses. Later on in the 1990s, as digital subtraction angiography was established as a routine 
method for the diagnosis of severe PAD, several studies re-evaluated the anatomic pattern of PAD 
(Ciavarella et al., 1993, Faglia et al., 1998). These studies confirm the more frequent involvement 
of calf arteries in diabetic patients, and this phenomenon seemed to be particularly evident in 
diabetics with foot ulcers (Faglia et al., 1998). 
 
The present study confirms the earlier findings of the tendency in diabetics to have a more diffuse 
form of PAD in their calf arteries than non-diabetics, while the superficial femoral artery seemed to 
remain less attenuated compared to patients without diabetes. It is unknown why the distribution of 
atherosclerosis differs between patients with and without diabetes. In our patient material, diabetics 
had severe symptoms (ulcers) more often than non-diabetics upon arrival at the hospital. This is 
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probably due to the diminished sense of pain in the neuropathic foot, but as to whether the more 
progressed disease affects the present DSA findings remains speculative. However, a considerable 
part of our patients suffered from a very severe form of PAD, and as many as 28 out of 98 patients 
were not able to perform the treadmill test due to their inability to walk at all, which was attenuated 
in the group of diabetic patients. 
 
One possible bias in the present study is that the number of participants is low, which can cause a 
certain skew as to the matching of the study groups. However, the numbers of patients in the 
original referred articles were 77 (Strandness, Priest and Gibbons, 1964) and 189 (Haimovici, 
1967), and in Conrad’s study, only 20 extremities amputated for gangrene were included (Conrad, 
1967).  
 
5.2 Diabetes as a risk factor in operative treatment of critical limb ischemia 
 
There are over 500,000 diabetics in Finland, and it has been estimated that their number will double 
during next 10–15 years (Onkamo et al., 1999) (Duodecim Diabetes Käypä hoito Duodecim 
2007;123(16):1985-6). Combined with the aging of the population, this will have a great impact on 
vascular surgery. The association between DM and postoperative mortality as well as cardiac 
morbidity is strong, but the role of DM as an independent risk factor has been unclear. Several 
studies (Eagle et al., 1996, Eagle et al., 1989a, Lee et al., 1999a)(Biancari et al., 2007) have 
considered DM  an independent risk factor for perioperative mortality in non-cardiac surgery, in 
association with silent ischemia, low ejection fraction and compensated heart failure. However, 
other studies (Axelrod et al., 2002, Hamdan et al., 2002) have found that DM alone does not explain 
the higher mortality or cardiac morbidity rates associated with major vascular procedures. In our 
study based on the Finnvasc registry of 5,709 operations, DM was not an independent risk factor for 
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early postoperative mortality in CLI, but morbidity in diabetics was increased and associated with 
old age, male sex, known CHD and urgent surgery. 
 
The reason for the higher morbidity and mortality among diabetics is often widespread 
atherothrombotic disease, and it has been estimated that approximately 75% of all deaths in 
diabetics are due to cardiovascular causes (Bierman, 1992). Another well-accepted observation is 
that patients undergoing major vascular operations are at significant risk of perioperative cardiac 
morbidity and mortality, and especially patients with DM have been considered to have an elevated 
risk of cardiac complication (Eagle et al., 2002, Axelrod et al., 2002). The present unadjusted 
complication rates suggested that patients with DM had a significantly higher rate of postoperative 
deaths, cardiac complications as well as cerebrovascular and renal complications, in addition to 
above-knee amputations and superficial wound infections. This incremental risk, however, mostly 
depended on the higher levels of specific co-morbidities among diabetic patients, such as 
hypertension, hyperlipidemia, congenital heart disease and renal insufficiency as well as more 
severe ischemia as an indication for the procedure. After adjusting these differences, we found no 
significant differences in early postoperative cerebrovascular and renal complication rates, but the 
rate of postoperative cardiac complications remained significantly higher in diabetics.  
 
Although DM does not appear to have an independent impact on postoperative mortality rates, 
diabetics have several prominent problems affecting their outcome after vascular surgery 
procedures, including an increased risk to develop postoperative wound infections and to undergo 
below-knee amputation. Diagnosing a diabetic foot is difficult because of masking by neuropathy 
which causes a delay in diagnosis and the initiation of effective treatment. If there is extensive 
tissue loss, especially with deep infection, amputation can be inevitable despite successful 
revascularisation.  
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In one Finnish study, limb salvage was not achieved in 8% of the patients with CLI despite 
successful revascularisation, as they were referred to vascular surgery too late (Eskelinen et al., 
2003). In our studies, the indication for the operation or DSA in the diabetic group was gangrene or 
ulceration more often than in non-diabetics, which emphasised the problem and delay in the 
diagnosis of a diabetic foot.  
 
Femorodistal bypasses are performed significantly more often for diabetics than for non-diabetics, 
which is in accordance with the more distal locations of arterial lesions in diabetics than in non-
diabetics. More distal and severe arterial occlusions are also one probable reason for the higher 30-
day below-knee amputation rate following revascularisation that was seen in our study. DM also 
remained an independent risk factor for early below-knee amputation when the differences in the 
preoperative stage of ischemia were taken to into consideration. One in three graft occlusions led to 
amputation within one month in both diabetics and non-diabetics, and the acute graft occlusion rate 
was equal in both groups, which further emphasises the independent role of DM in increasing the 
risk of amputation. In cases in which the graft was patent at 30 days, significantly more diabetics 
than non-diabetics underwent amputation, which supports the notion that in diabetics, 
reconstruction is often performed late and that diabetics more commonly must undergo amputation 
due to major tissue loss, despite successful revascularisation.      
 
The weakness of the study is that registry data is always somewhat inaccurate. Especially the 
registration of risk factors may be unreliable (Lepantalo et al., 1994, Kantonen et al., 1997). 
However, if a patient has diagnosed diabetes, it is well-documented in the patient’s records. 
Therefore, diabetes is probably one of the most reliably registered risk factors. Kantonen et al. 
audited the reliability of the Finnvasc data (Kantonen et al., 1997), and one of the most accurate 
types of data were postoperative complications. The number of patients is high in the current study, 
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and in spite of certain inaccuracies, registry data can be used in the study, and we believe the results 
to be reliable. 
 
 
5.3 Endovascular treatment of claudication and CLI as well as impact on QoL 
 
The role of endovascular treatment of PAD has increased significantly during the last five years. 
Even at the end of the last decade, the general opinion was that PTA should not be considered as a 
primary treatment for CLI except in extraordinary circumstances (Parsons et al., 1998), but the 
enthusiasm toward PTA due to improvements in endovascular technology and expertise has led to 
the suggestion that PTA should be the first choice for most of the patients requiring lower-extremity 
revascularisation (Nasr et al., 2002)  (Adam et al., 2005). According to the BASIL trial with 
patients presenting with severe limb ischemia due to infra-inguinal disease and suitable for surgery 
and angioplasty, both the PTA-treated and the surgically treated groups were associated with 
broadly similar outcomes in terms of amputation-free survival, and in the short term, surgery was 
more expensive than angioplasty (Adam et al., 2005). However, with the high failure and re-
intervention rate associated with PTA, the apparently improved durability and reduced re-
intervention rate of the bypass method favours surgery for patients expected to live more than two 
years and who are relatively fit (Adam et al., 2005). 
 
The fact is that one of the primary goals of vascular surgical interventions besides limb salvage and 
graft patency is to improve the patients' quality of life. The impact of PTA on the QoL of 
claudicants has been recognized (Currie et al., 1995) (Chetter et al., 1998), but QoL studies with 
CLI patients are based mainly on bypass surgery treatments (Klevsgard et al., 2002)(Wann-Hansson 
et al., 2005), with few studies reporting an over six-month follow-up (Wann-Hansson et al., 2005). 
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One problem is that although the TransAtlantic Inter-Society Consensus (Norgren et al., 2007) 
recommended that QoL should be evaluated in clinical trials, there are at present no established 
disease-specific questionnaires for QoL assessment in patients with CLI. There are, however, two 
generic instruments, the NHP and SF-36, which have been evaluated on the basis of validity, 
reliability and responsiveness analyses by Klevsgård et al. (Klevsgard et al., 2002) as suitable for 
detecting changes in QoL as regards the treatments for CLI. 
 
The technical success of PTA procedures in our study was 100%, and postoperative complications 
were rare. Furthermore, the clinical success for claudication patients was good: Only one PTA-
treated segment was occluded at one year’s follow-up, and more than 80% of the patients were free 
of claudication. As a whole, the present study demonstrated the poor outcome of CLI patients with 
high mortality and morbidity rates; however, one third of CLI patients survived with no critical 
ischemia at one year’s follow-up. The patients with rest pain seemed to have received more 
benefits, whereas the outcome was poorer in legs with tissue loss. 
 
A recent study on peripheral angioplasty for CLI produced findings that support our results. In a 
study on infra-popliteal angioplasty for critical limb ischemia, Giles et al. (Giles et al., 2008) 
suggested that an attempt at PTA may be indicated as an alternative to primary amputation for 
patients who are not candidates for bypass, although restenosis, re-intervention or amputation rates 
are naturally high. Although the overall survival rates of the 163 patients included in the study were 
80%, 63% and 54% at 1, 2, and 3 years, respectively, the authors achieved a limb salvage rate of 
84% at 3 years for this very challenging group of patients (Giles et al., 2008). In a study by Faglia et 
al. (Faglia et al., 2007), PTA proved effective in avoiding major amputation if re-canalisation 
occurred in at least one tibial artery down to the foot, but in a few of their patients, re-canalisation 
of the peroneal artery alone was not sufficient to avoid major amputation. In their analysis, the risk 
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of major amputation remained very high if PTA was performed only in the femoral-popliteal 
segment, thus leaving crural segments obstructed (Faglia et al., 2007). 
 
The outcome of unreconstructed CLI is very poor in terms of both survival and limb salvage 
(Norgren et al., 2007). In a study on the outcome of 105 unreconstructed CLI patients and 136 legs, 
the limb salvage rates were 81%, 70% and 54% at 1, 3 and 12 months, respectively, with the 
respective survival rates amounting to 93%, 77% and 46% (Lepantalo and Matzke, 1996). 
Therefore, attempting PTA procedures seems justified in this special group of CLI patients in order 
to avoid major amputation and, particularly, if this will have sufficient impact on the patient’s QoL. 
 
Filling out the NHP questionnaire independently proved difficult or even impossible for many of 
our patients especially among the CLI patients who are older and whose more serious illness causes 
varying levels of disability. For a significant number of the patients, the questions involving the 
domains of social isolation and emotional reactions caused embarrassment, and the results in that 
domain were not reliable. The questions in the domains of energy, pain and mobility were more 
tolerated, and patients found them easier to answer. The sensitivity of the NHP domains of pain and 
physical mobility, associated with the severity of ischemia, has been proven earlier in other studies 
(Wann-Hansson et al., 2004). Because there were only 11 CLI patients remaining after one year of 
follow-up who were able to answer the questions, the differences between the mean values did not 
reach statistical significance. However, in this group of patients, the scores in the domain of pain 
improved postoperatively, and the improvement continued up to the one-year control. In the domain 
of physical mobility, the improvement for claudicants was clear and statistically significant, but this 
improvement disappeared during one-year follow-up, and for the CLI group, there were no changes 
in the QoL value of mobility. The explanation for this is that PAD patients have several other co-
morbidities effecting mobility, and especially CLI patients with severe limb ischemia stay relatively 
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immobile although leg salvage is achieved, and the aging of the patient groups certainly has an 
adverse effect. 
 
5.4 Predictors for the immediate and long-term outcome of a vascular surgical procedure 
 
Although CLI patients have several co-morbidities and their risk profile is extremely high with 
regard to surgical procedures, there are no simple scoring methods available at present for this 
specific group of patients. The GAS has appeared to be a good predictor of outcome after elective 
open repair of an AAA, and it is also simple to use as an instrument for preoperative risk 
stratification (Biancari et al., 2003) – these advantages attracted us to test the method on elective 
vascular surgery patients.  
 
Our study showed that GAS has predictive value for the prognosis after vascular surgery 
procedures, and because the survival form infrarenal aortic and infrainguinal procedures was 
similar, the use of GAS in surgical procedures for CLI needs to be validated externally.  Based on 
our study, the estimation is that GAS selects low-risk patients well and is useful in identifying high-
risk patients, but the drawback is that, on the individual level, suitability for operations must be 
considered separately for the high-risk group. The number of patients included in the current study 
is too low to make far-reaching conclusions, but the findings may be useful in evaluating individual 
patients in everyday clinical work. 
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6 CONCLUSIONS 
 
1. Diabetics had fewer stenoses in the superficial femoral arteries, and they had a tendency 
towards more diffuse atherosclerotic changes in their crural arteries compared to 
nondiabetics.  
2. Diabetes alone was not an independent risk factor for early postoperative mortality after 
lower limb revascularization for CLI, but the morbidity seemed to be increased in diabetics 
in association with old age, male sex, coronary artery disease and renal insufficiency, as 
well as urgent surgery. Diabetes was an independent risk factor for early postoperative 
myocardial ischemia, BK amputation and wound infection.  
3. PTA resulted in an immediate improvement in the quality of life in claudicants, but this 
effect was not seen in the long term. In CLI there was a subgroup of patients who gained 
significant benefits in terms of both limb salvage and the quality of life. 
4. A low GAS value (<77) predicted low mortality after surgery, while a higher risk score was 
clearly associated with higher mortality. However, due to its low predictive value, GAS is 
not accurate in attempting to identify patients who will not survive surgery even in the high-
risk patients (GAS>77).  
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ABSTRACT
Background: To compare the extent of angiographically detected stenoses in different
segments of the lower leg arteries in diabetics and nondiabetics.
Methods: The study group consisted of 60 nondiabetic and 38 diabetic patients with lower
extremity disease and no previous vascular interventions. Arterial lesions were analysed by
digital subtraction angiography (DSA). The patients were evaluated by walking distance and
ankle-brachial index (ABI) and the reason for hospitalization was recorded.
Results: Statistically significantly fewer stenoses were found in the superficial femoral artery
in diabetics than in nondiabetics. Although a tendency to more diffuse changes in crural
arteries was found, no statistically significant difference were found in other segments of the
lower leg arteries apart from the femoral arteries.
Conclusions: Judging from the present results there are fewer angiographically detectable
stenoses in the superficial arteries in diabetics than nondiabetics.
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INTRODUCTION
Diabetes is an important independent risk factor for
peripherial atherosclerotic disease(1). Previous studies
have demonstrated that diabetics differ from other
individuals in the location of occlusive atherosclerotic
disease.  Cast studies and angiographic examinations
have shown diabetics to have more stenotic disease in
the calf vessels than nondiabetics, particularly in the
peroneal and posterior tibial arteries. Furthermore, the
arteriosclerotic process is more diffuse in the diabetic
group (2,3,4). In foot vessels diabetics seem to have
even fewer stenoses than nondiabetics (3) and
surprisingly, fewer stenotic lesions have been found in
some lower leg arteries in diabetics than nondiabetics
(5,6). If this is indeed, the case some factor in diabetics
or their lower leg arteries must be assumed to protect
their superficial femoral arteries against
atherosclerosis.
The purpose of the present pilot study was to establish
whether there really are fewer stenoses in some lower
leg arteries in diabetics than in nondiabetics
MATERIALS AND METHODS
We evaluated all vascular patients during the period
November 23, 1999 to September 4, 2000 at our
vascular surgery outpatient clinic and first aid
department. The patients referred because of suspected
circulatory problems in their lower extremities. DSA
was performed on all those who were considered to
need invasive treatments. Patients who had previously
undergone vascular surgical or radiological
interventions  were excluded from the study. The final
cohort comprised 98 patients, their age varying
between 34 and 90 years, mean age 68.9 years.
Furthermore, 60 (61.2 %) of them were nondiabetics
and 38 (38.8 %) diabetics. Four patients in the
nondiabetic group had no DSA available for their legs,
and two for their their feet. One of the patients had
thrombosis of the distal aorta (Leriche syndrome) and
the rest had total obstructions in upper part of the lower
extremity arterial trunk. Consequently, the
concentration of the contrast agent was too low for
analysis of the distal part of the arterial trunk. Diabetes
had previously been verified in health center or
hospital, and the diagnoses were assesed via the
medical record of internal disease. The duration of the
disease could not be sufficintly reliably determined in
all cases. (Table1).
Table 1. Characteristics of patiens.
Diabetes
No Yes Total
Number of patients 60 38 98
Male/female 28/35 24/14 52/46
Age (range) 43-89 34-90 34-90
  Mean
  Median
68.5
69.5
69.5
71.5
68.9
70.0
Walking distance was measured by  treadmill test. The
patients walked 500 meters at a speed of 3,6 km per
hour, and if the exercise caused any claudicational pain
intense enough to stop the walking, this was noted.
ABI was performed by  Imex Lab 9000R test. The test
uses pressure cuffs to measure the left and right
systolic brachial pressures simultaneusly, and
photopletysmography (PPG) probes to sense the blood
flow.
DSA (Siemens Polytron/Angiostar) was performed on
all patients in aortic flush manner (Ultravist 300
mgI/ml). Right femoral access, under local anesthesia,
was the method used. Each study was later evaluated
by the same experienced angiologist who had no
previous information as to whether a patient was
diabetic or nondiabetic. The extent of the stenosis in
each vessel segment was determined visually and
displayed numerically (Figure 1). The scoring system
used was modified from an article by Faglia and
associates. (7). The highest lumen reduction in each
segment determined the score for the segment. This
was 0 if the lumen was reduced to 50% or less at its
narrowest point, 1 if the reduction was 50-75 %, 2 if
the reduction was 76-99 % and 3 if there was a total
occlusion. In the foot the score was 0 if there was at
least one arterial trunk (i.e. dorsal or plantar artery)
patent, and 1 if both were invisible.
Figure 1. The illustration of the scoring system.
SUPRAINGUINAL
SEGMENT
Distal aorta
A.iliaca communis
A.iliaca externa
A.femoralis communis
FEMORO-POPLITEAL
SEGMENT
A.femoralis profunda
A.femoralis superficialis
A.poplitea
LEG AND FOOT
A.tibialis anterior
A.fibularis
A.tibialis posterior
A. plantaris pedis
A. dorsalis pedis
SCORE:
0= < 50% STENOSIS
1= 50 - 75 % STENOSIS
2= 75 - 99 % STENOSIS
3= OCCULUSION
FOOT  0 = A.DORSALIS  PEDIS OR A.
PLANTARIS PEDIS OPEN
FOOT 1 = NO VASCULAR LUMEN
Angiology and Vascular Surgery Vol 11 No 1/2005
The data were statistically analyzed using SPSS
(Statistical Package for Social Sciences). To test the
normality of the distributions of the variables the
Kolmogrov-Smirnov test was used. Furthermore, since
the variables were not normally distributed, and as in
some cases there were only a few observations in a
group, nonparametric methods were used. Because the
tests applied are designed for independent
observations, both legs of the same person were not
studied concurrently. The leg with more severe
symptoms was chosen for the main study, but also the
other leg of diabetics and nondiabetics was compared.
Differences in the mean values of the variables
between diabetics and nondiabetics were analyzed by
Mann-Whitney test. Associations between pairs of
variables were studied using the Chi-squared test or
Spearman’s correlations.
RESULTS
Claudication was the most common reason for referral
for further examinations in hospital in both groups.
However, foot ulcers were almost as common in
diabetics. Rest pain, cold feet, failures in foot
circulation, swelling and discolored skin were
mentioned less frequently (Table 2).
Walking distance ranged from 17 to 500 meters, mean
value 230 meters; 28 patients were not able to take a
treadmill test. There were 11 patients who had
substantial ulcers in the foot, and five suffered from
severe rest pain, not being able to walk. Furthermore,
three patients had hemiplegia after cerebral infarction,
and nine suffered from general weakness due to old
age.  There were no significant differences between
diabetics and nondiabetics in the walking distance
achieved (Table 3).
Table 2. Reason for referral for further examinations.
Symptom (N/%) Diabetes
No Yes Total
Claudication 47 13 60
         % 78,3 34,2 61,2
Ulcers 6 12 18
         % 10.0 31.6 18.4
Rest pain 4 9 13
         % 6,7 23,7 13,3
Other 3 4 7
         % 5,0 10,5 7,1
cold feet
swelling
skin pigmentation
failure in circulation
ABI ranged from 0,23 to 1,01, the mean value being
0,62. In 21 cases ABI had not been evaluated, either
because the patients had arrived in hospital from the
first aid department, or it could not be defined because
of uncompressible arteries. There were no significant
differences in ABI values between diabetics and
nondiabetics. The ABI value was missing or could not
be taken slightly more often in the diabetics group
(Table 3).
In scoring analysis there were no significant
differences in distal aorta, iliaca and femoralis
communis levels. At femoro-popliteal levels the
angioscore value was lower in the diabetic group
mainly due to the femoralis superficialis, which
appeared to have significantly fewer stenoses in the
diabetic group.
In calf vessels there were no significant differences in
total score between the two groups when all three
arteries were measured concurrently.  Nondiabetics
seemed to have fewer changes in single arteries, but the
grade of  stenosis was somewhat higher. Diabetics
tended to evince minor changes more often in all three
arteries, and thus their atherosclerotic disease was
evidently more diffuse. Nondiabetics were likely to
have a total stenosis of the tibialis anterior slightly
more often than diabetics.
In foot arteries there were no significant differences
between the two groups (Table 4).
Table 3. Walking distance and ankle-brachial index
Diabetes
No Yes Total
Walking distance
Mean 231 227 230
Median 200 162 188
Min/Max 20 – 500 17 – 500 17 – 500
Missing 11 17 28
ABI
Mean 0.61 0.63 0.62
Median 0.60 0.62 0.60
Min/Max 0.23 – 1.01 0.25 – 0.99 0.23 – 1.01
Missing 7 14 21
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Table 4. The summation of the scoring analyze.
Diabetes
No Yes P
Aortofemoral
segment
(N) 60 38
Mean 0,83 0,37 0,068
Median 0,00 0,00
Min/Max 0/6 0/4
Distal aorta
(N) 60 38
Mean 0,08 0,03 0,599
Median 0,00 0,00
Min/Max 0/3 0/1
A.Iliaca communis –
A.femoralis
communis
(N) 60 38
Mean 0,75 0,34 0,070
Median 0,00 0,00
Min/Max 0/3 0/3
A.femoralis –
A.Poplitealis sement
(N) 60 38
Mean 0,75 1,95 0,024*
Median 3,00 2,00
Min/Max 0/6 0/7
A.femoralis
profunda
(N) 60 38
Mean 0,32 0,37 0,877
Median 0,00 0,00
Min/Max 0/3 0/3
A.femoralis
superficialis
(N) 60 38
Mean 1,55 1,00 0,037*
Median 2,00 0,50
Min/Max 0/3 0/3
A.poplitea
(N) 60 38
Mean 0,87 0,58 0,265
Median 0,00 0,00
Min/Max 0/3 0/3
Leg and foot
(N) 54 38
Mean 4,69 5361 0,170
Median 6,00 6,00
Min/Max 0/10 0/10
A.tibialis ant.
(N) 58 38
Mean 1,66 1,79 0,758
Median 2,50 2,00
Min/Max 0/3 0/3
A.fibularis
(N) 58 38
Mean 1,09 1,53 0,113
Median 0,00 2,00
Min/Max 0/3 0/3
A.tibialis post.
(N) 58 38
Mean 1,76 2,13 0,238
Median 3,00 3,00
Min/Max 0/3 0/3
Foot
(N) 54 38
Mean 0,22 0,16
Median 0,00 0,00
Min/Max 0/1 0/1
*statistically significant difference
DISCUSSION
There are over 180 000 diabetic patients in Finland,
almost 90 % of them suffering from non - insulin
dependent diabetes mellitus. In Finland the incidence
of type 1 diabetes has remained highest in the world (8)
and the prevalence of NIDDM is relatively high (9).
Over 11 % of the total expenses of health care are
attributable to diabetes and its complications. In
treatment the major proportion of expenses is due to
heart and vascular diseases (10). According to the
Finnish national vascular registry (FINNVASC),
diabetes is estimated to be in 24,9% of cases a risk
factor for patients treated surgically or endovascularly
for peripheral vascular diseases (11). In a recent study
from FINNVASC the data showed that diabetes
mellitus and renal insufficiency increased the relative
risk of amputations and mortality when evaluated by
early results of endovascular treatment of chronic
critical ischemia (12). Diabetics are believed to have a
so-called ”small vessel disease” at arteriolar level, not
amenable to surgical reconstruction. The belief persists
and causes delay in adequate treatment for these
patients. The prevalence of atherosclerotic occlusive
disease appears to be approximately five times higher
among patients with NIDDM, and the risk of arterial
occlusive disease of the lower extremeties is also high
when compared to nondiabetics (13).
In many previous cast or angiographic studies of
diabetics with arterial occlusive disease, the symptoms
of patients with lower extremity disease have been very
severe. For example, cast studies have been made on
amputated legs (3), and all patients in a study by
Ciavarella and associates (5) had critical limb ischemia.
In the present study, the severity of the symptoms
varied more from suspected lower leg extremity arterial
disease to foot ulcers and rest pain.
DSA is considered the golden standard in the diagnosis
of vascular disease. It has certain disadvantages, not
always showing patent distal vessels because of
proximal stenoses or due to timing problems compared
to the latest methods of magnetic resonance
angiography (MRI) (14,15). The availability of  MRI-
based methods is as yet inadequate but their role in
visualizing vascular diseases is certain to expand in the
future.
In our patient material diabetics had severe symptoms
(rest pain, ulcers) more often than non-diabetics upon
arrival at the hospital. This is probably due to the
diminished sense of pain in the neuropathic foot,
resulting in underestimation of the disease, and thus in
harmful delay in the initiation of adequate treatment.
Angiographic findings evinced no significant
differences at distal aorta, iliaca and femoralis
communis levels. At femoro-popliteal level diabetics
had significantly fewer stenoses than nondiabetics.
Smoking has previously been connected to proximal
atheroscerotic disease (5) but the reliability of
patients’ reports of smoking habits has turned out to be
poor and hence history of smoking is not included in
this report. In calf vessels and foot arteries we found no
significant differences in total score between the two
groups of patients, but the atherosclerotic disease
seems to be more diffuse in the calf vessels of
diabetics.
To conclude, DSA could not confirm all previous
reported differences between these two patient groups.
In the present pilot study of 38 diabetics and 60
Angiology and Vascular Surgery Vol 11 No 1/2005
nondiabetics statistically significantly (p = 0.037)
fewer angiographic stenoses were found in the
superficial femoral arteries of diabetics as against
nondiabetics. If these findings are confirmed in a larger
cohort, it would be interesting to clarify why diabetes
protects the femoral artery from atherosclerosis.
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Diabetes as an independent risk factor for early
postoperative complications in critical limb
ischemia
Jyrki Virkkunen, MD,a,b Maarit Heikkinen, MD,b Mauri Lepäntalo, MD,c Riina Metsänoja, MSc,d
Juha-Pekka Salenius, MD,b and the Finnvasc Study Group, Jyväskylä, Tampere, and Helsinki, Finland
Objective: The purpose of this study was to evaluate the significance of diabetes mellitus as a risk factor for postoperative
major morbidity and mortality after surgery for critical lower limb ischemia (CLI).
Subjects: A national vascular registry (Finnvasc)–based survey included 5709 operations for CLI from 1991through 1999.
Of these operations, 2508 (44%) were performed on diabetics. Tissue loss was the indication for surgery in 77% of
diabetics and in 52% of nondiabetics. The proportion of femorodistal bypasses was 43% in diabetics and 24% in
nondiabetics, whereas the proportion of reconstructions for aortofemoral arterial occlusive disease was 16% in diabetics
and 34% in nondiabetics.
Results: Thirty-day mortality was 4.5% in diabetics and 3.4% in nondiabetics (P  .05). The rate for early below-knee
amputation was 6.5% in diabetics and 3.3% in nondiabetics (P < .001). Independent factors for postoperative death were
aortofemoral reconstruction (odds ratio [OR], 4.0), preoperative cardiac risk factor (OR, 3.1), primary surgery (OR,
2.0), renal insufficiency (OR, 1.9), urgent surgery (OR, 1.7), and age (OR, 1.3). Diabetes was an independent risk factor
for postoperative below-knee amputation (OR, 1.7), cardiac complications (OR, 1.5), and superficial wound infection
(OR, 1.3). There was an inverse association between diabetes and acute graft occlusion (OR, 0.8). Independent risk
factors for early postoperative mortality in diabetes were aortofemoral reconstruction (OR, 2.5), urgent surgery (OR,
2.0), male gender (OR, 2.0), renal insufficiency (OR, 1.9), cardiac risk factor (OR, 1.7), and age (OR, 1.4). In
nondiabetics independent risk factors for early postoperative mortality were aortofemoral reconstruction (OR, 4.5),
cardiac risk factor (OR, 3.6), primary surgery (OR, 2.6), and extra-anatomic bypass (OR, 2.3).
Conclusions: Diabetes was not an independent risk factor for early postoperative mortality in CLI as there was an increased
morbidity in diabetics associated with old age, male gender, known coronary artery disease, and renal insufficiency, as well
as urgent surgery. As diabetics have increased proclivity for these factors, special attention needs to be paid to their
preoperative assessments. ( J Vasc Surg 2004;40:761-7.)The issue of the role of diabetes mellitus (DM) as a
risk factor for vascular surgery is important because a
large proportion of vascular surgical patients have DM.
In the future, their number will increase due to the aging
of population.1,2 This is particularly true in patients with
critical lower limb ischemia (CLI), ie, legs with threat-
ened viability. Cardiovascular events are the main reason
for perioperative mortality and morbidity after vascular
surgery, and it has been suggested that DM further
increases the risk.3,4 There is an unquestionable associa-
tion between diabetes and immunologic dysfunction,
which is supposed to expose diabetics to infections.5
Diabetes is also associated with renal and cerebrovascular
complications and worse outcome of vascular opera-
tions, including risk of major amputation after infrain-
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doi:10.1016/j.jvs.2004.07.040guinal surgery 6,7; yet contradictory data exist as well.8,9
In a study of outcome following femorotibial reconstruc-
tion, Luther and Lepäntalo8 showed that patency, leg
salvage, and survival were lower for diabetics than for
nondiabetics, but this difference was entirely caused by
low patency and leg salvage rates in diabetic women.
Akbari et al9 showed that DM does not influence late
mortality, graft patency, or limb salvage rates after lower
extremity arterial reconstruction.
The aim of the present study was to use data from a
nationwide 9-year registry-based study to analyze the sig-
nificance of diabetes as a risk factor for early postoperative
mortality and morbidity in vascular reconstructions.
MATERIAL AND METHODS
Systematic data collection of all vascular procedures
into national Finnvasc registry was started 1991 in
Finland. The details of Finnvasc protocol have been
described elsewhere by Salenius et al.10 The protocol
consisted of preoperative patient data, including risk
factors and the indication for surgery; operative details,
such as urgency, procedure code, and anatomy, graft
material; as well as data concerning the 30-day outcome,
including postoperative complications, reoperations,
and patency. The overall number of recorded variables
was over 200. All arterial surgery, including endovascular761
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registry. During the period from 1991 to 1999 all 5
university hospitals, all of the 16 central hospitals, and
the 4 largest district hospitals participated in the registry.
In each hospital, there was 1 vascular surgeon responsi-
ble for data collection and validity of the data. In hospi-
tals information was recorded in paper form and sent to
central office in Tampere, where data were entered into
the computer using Paradox 4.0 software. Data for a
total of almost 40,000 surgical and endovascular proce-
dures are included in the database.
In the present study, all surgical procedures performed
for CLI were selected for the analyses. Critical ischemia was
defined according to Fontaine classification as F III or F IV,
ie, ischemic rest pain, nonhealing ulcer or tissue defect, or
gangrene irrespective of the distal ankle-brachial index
(ABI). Risk factors for perioperative death and morbidity
were analyzed with special emphasis on differences between
diabetics and nondiabetics.
Logistic multiple regression was used to analyze the
influence of factors affecting postoperative 30-day out-
come. Analyzed independent factors were:
● Age
● Gender
● Cardiac risk factor: previously documented myocardial
infarction and/or ongoing angina pectoris or previous
coronary bypass surgery
● Diabetes: hyperglycemia requiring diet, oral medication,
or insulin treatment
● Hypertension: medication for hypertension or arterial
pressure 160/95 mm Hg
● Cerebrovascular disease: history of stroke or transient
ischemic attacks
● Pulmonary disease: asthma or chronic obstructive pul-
monary disease
● Renal failure: creatinine  150 umol/L
● Smoking: current smoker
Table I. Demographic data and preoperative risk factors o
Total
Mean age (SD) 71.4 (10.8)
Male:female (%) 50 : 50
Hyperlipidemia* 7.6
Hypertension† 37.2
Cardiac‡ 50.7
Cerebrovascular§ 14.9
Pulmonal

11.3
Renal¶ 7.2
Smoking** 29.5
**ns, Nonsignificant.
*Serum concentration of cholesterol 6.5 mmol/L or of tryglycerids 2.0
†Medication for hypertension or arterial pressure 160/95 mm Hg.
‡Previously documented myocardial infarction and/or ongoing angina pec
§All grades of stroke including transient ischemic attacks.
Asthma or chronic obstructive pulmonary disease.
¶History of chronic and acute renal failure, and/or serum level of urea ove
smoker.● Indication for surgery, divided into the following 3
categories: rest pain, ulceration, and gangrene
● Anatomic level and extent of the procedure, divided
into the following 5 main categories: aortoiliac or
femoral reconstruction, extra-anatomic reconstruc-
tion for central peripheral arterial occlusive disease
(PAOD), femoral endarterectomy including profun-
doplasty, femoropopliteal reconstruction, and femo-
rodistal reconstruction
● Urgency of the procedure (elective, urgent) and whether
procedure was primary or secondary
Dependent (30-day outcome) factors that were ana-
lyzed included the following:
● Mortality
● Cardiac complication: myocardial infarction or ischemia
with electrocardiogram changes and/or raised troponin
levels
● Cerebrovascular complication: stroke or transischemic
attack
● Renal complication: renal failure with raised serum cre-
atinine level from 150 umol/L up to irreversible renal
insufficiency requiring dialysis
● Respiratory complication: pulmonary embolism, pneu-
monia, or pulmonary edema
● Superficial wound infection: local wound infection
which was cured with local care and antibiotics and did
not need revision or drainage in operating room
● Below-knee (BK) amputation
● Above-knee (AK) amputation
● Multiorgan failure
● Acute occlusion of the graft or endarterectomized seg-
ment after the surgery
In addition, separate analyses were done for each
group, diabetics and nondiabetics, to find out if there were
study patients
abetics Nondiabetics P
(11.0) 71.7 (10.5) .001
1 : 49 58 : 42 .001
8.4 7.0 .05
41.7 33.7 .001
55.9 46.6 .001
15.7 14.2 ns
8.3 13.7 .001
11.0 4.0 .001
16.8 39.4 .001
l/L.
mol/L, and/or creatinine serum level greater than 150 mol/L. Currentf the
Di
70.5
5
mmo
toris.
r 20 m
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mortality. Analyzed independent factors were the same as
those listed previously, with diabetes as a discriminator.
The total number of operations for critical limb isch-
emia from 1991 through 1999 was 5709; of them 2508
were performed on diabetics (43.9%). Diabetics had signif-
icantly more hypertension, hyperlipidemia, and cardiac and
renal involvements than nondiabetics, whereas smoking
and pulmonary insufficiencies were more unusual among
diabetics (Table I).
The most common manifestation of CLI was ulcer-
ation in 2893 patients (51.6%), followed by rest pain in
2125 patients (37.9%) and gangrene in 691 patients
(10.5%). Diabetics more often had ulceration or gangrene
as an indication compared with nondiabetics (Table II).
The most common procedure in diabetics was femorodistal
bypass (43.0%) whereas femoropopliteal bypass was most
frequent in nondiabetics (28.1%). The proportion of femo-
rodistal bypasses was higher in diabetics than in nondiabet-
ics (43.0% and 24.1 %, respectively) whereas the proportion
of reconstructions for aortoiliac arterial occlusive disease
was lower in diabetics compared with nondiabetics (16.0 %
and 33.4 %, respectively) (Table III).
Statistical analysis. Results were expressed as mean
(standard deviation). Differences between means were
tested for significance by using the 2-tailed Student t test.
Comparison of proportions was performed by using the
Pearson 2 test or calculating the odds ratio (OR). Multi-
variate analysis was performed by using logistic regression.
P values .05 were considered significant. Data analysis
was carried out by using the SPSS/Win version 11.0.
Table II. Indications for the operation in diabetics and no
Diabetics
n %
Rest pain 582 23.2
Ulceration 1485 59.2
Gangrena 441 15.7
Total 2508 100
Table III. The type of operation for critical limb ischaem
Total
n
Aortoiliac or femoral reconstruction 574 1
Extra-anatomic bypass for aortoiliac PAOD 899 1
Femoral endarterectomy* 491
Femoropopliteal bypass 1610 2
Femorodistal bypass 1850 3
Other 285
5709 10
ns, Nonsignificant.
*Including profundoplasty.RESULTS
30-day mortality after the procedure was 3.9%. The
most common complication was superficial wound infec-
tion (12.8%), followed by acute graft occlusion (9.8%) and
cardiac complication (7.0%) (Table IV). BK amputation
was performed in 4.7% and AK amputation in 3.4% within
30 days of the procedure. In diabetics, 37.4% of patients
whose graft occluded immediately after vascular surgery
underwent early amputation compared with 32.6% of non-
diabetics (not significant). The 30-day amputation rate in
patients whose graft was open was 7.3% in diabetics com-
pared with 3.7% in nondiabetics (P  .0001)
In multivariate analysis aortofemoral reconstruction
(OR, 4.0), preoperative cardiac risk factor (OR, 3.1), pri-
mary surgery (OR, 2.0), renal insufficiency (OR, 1.9),
urgent surgery (OR, 1.7), and age (OR, 1.3) were found to
be independent factors for postoperative death (Table V).
Diabetes was not an independent risk factor for 30-day
mortality after the procedure (OR, 1.3; 95% confidence
interval [CI], 0.95-1.75; P .08). In multivariate analysis,
diabetes was found to be an independent risk factor for
postoperative BK amputation (OR, 1.7), cardiac complica-
tions (OR, 1.5), and superficial wound infection (OR, 1.3)
(Fig 1). There was an inverse association between diabetes
and acute graft occlusion (OR, 0.8).
Logistic regression modeling was also used to evaluate
if there were differences between diabetics and nondiabet-
ics in the predictive value of various pre- and intraoperative
factors for 30-day outcome. Aortofemoral reconstruction
(OR, 2.5), urgent surgery (OR, 2.0), male gender (OR,
2.0), renal insufficiency (OR, 1.9), cardiac risk factor (OR,
betics
Nondiabetics Total
% n %
43 48.2 2125 37.9
08 44.0 2893 51.6
50 7.8 691 10.5
01 100 5709 100
diabetics and nondiabetics
Diabetics Nondiabetics
Pn % n %
128 5.1 446 13.9 .001
274 10.9 625 19.5 .001
196 7.8 295 9.2 ns
712 28.4 898 28.1 ns
1078 43.0 772 24.1 .001
120 4.8 165 5.2 ns
2508 100.0 3201 100.0ndia
n
15
14
2
32ia in
%
0.1
5.7
8.6
8.2
2.4
5.0
0.0
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early postoperative mortality in diabetics. In nondiabetics
independent risk factors for early postoperative mortality
were aortoiliac or femoral reconstruction (OR, 4.5), car-
diac risk factor (OR, 3.6), primary surgery (OR, 2.6), and
extra-anatomic bypass for central peripheral arterial occlu-
sive disease (OR, 2.3) (Table VI).
DISCUSSION
This registry-based study used Fontaine classification
for CLI. Systematic implementation of more objective cri-
teria might be impossible in a population-based study.
Furthermore, the use of pressure criteria would skew the
differences between diabetics with nondiabetics, as diabet-
ics are apt to have mediasclerosis and pseudohypertension.
The association between DM and postoperative mor-
tality and cardiac morbidity is strong, but the role of DM as
an independent risk factor has been unclear. Eagle et al11,12
Table IV. Early (30-day) complications in diabetics and n
Total
n %
Superficial wound infection 731 12.8
Below-knee amputation 270 4.7
Cardial complication 401 7.0
Cerebrovascular complication 94 1.6
Renal complication 70 1.2
Death 221 3.9
Acute graft occlusion 561 9.8
Respiratory complication 171 3.0
Above-knee amputation 194 3.4
MOF 24 0.4
ns, Nonsignificant; MOF, multiorgan failure.
Table V. Multivariate analysis of the risk factors for early
postoperative death
Odds
ratio 95% CI
Aortoiliac or aortofemoral reconstruction* 4.0† (2.5–6.4)
Cardiac risk 3.1† (2.3–4.4)
Primary compared to secondary surgery 2.0‡ (1.3–3.1)
Renal insufficiency 1.9‡ (1.2–2.9)
Extra-anatomic bypass for central PAOD* 1.8‡ (1.2–2.9)
Urgent compared with elective surgery 1.7† (1.3–2.4)
Age (per 10 y) 1.3† (1.1–1.4)
Diabetes 1.3 (0.95–1.7)
Male gender 1.3 (0.9–1.7)
Gangrena compared with rest pain 1.3 (0.8–2.0)
Cerebrovascular risk 1.2 (0.8–1.7)
Pulmonary risk 1.2 (0.8–1.8)
Femorodistal reconstruction* 1.2 (0.8–1.9)
Ulcer compared with rest pain 1.1 (0.8–1.6)
Femoral endarterectomy* 1.0 (0.5–1.8)
Smoking 0.9 (0.6–1.3)
Hypertension 0.8 (0.6–1.1)
*Compared to femoropopliteal reconstruction.
†P  .001.
‡P  .05.and Lee et al13 considered DM as an independent risk
factor for perioperative mortality in non-cardiac surgery,
associating with silent ischemia, low ejection fraction, and
compensated heart failure. In a registry-based study includ-
ing 6565 various vascular surgical procedures, including
lower extremity revascularizations, carotid, or aortic proce-
dures, Hamdan et al14 found that diabetes alone did not
explain a higher mortality or cardiac morbidity rate associ-
ated with major vascular procedures. Axelrod et al15 had
similar findings, concluding that DM did not appear to be
an independent risk factor for postoperative mortality.
These earlier studies included various types of vascular
procedures, which may have had a confounding effect on
the results. Our study included only vascular procedures
due to critical limb ischemia, making the study population
more homogeneous, with a higher propensity for coronary
artery disease.3
This survey was based on a large registry, which might
give rise to certain uncertainty as to the accuracy of the
material. The audit of Finnvasc registry has been published
twice, by Lepäntalo et al16 in 1996 and Kantonen et al17 in
1997. In the latter evaluation, the data were audited by
comparing the originally recorded Finnvasc forms and the
set of rerecorded forms filled in later. It was found that the
most inaccurate data were preoperative risk factors and
operation code; the overall data agreement with the origi-
nal data was 93 %, with a range among participating hospi-
tals of 81% to100 %. The number of missing cases was 19%.
The validity of Finnvasc data could be thus considered
acceptable for a nationwide registry despite the fact that the
data thereafter might be skewed because some hospitals
have been unable to participate in the registry during the
past 2 to 3 years.
In our material, there were significant differences be-
tween diabetics and nondiabetics in preoperative risk fac-
tors. The overrepresentation of coronary artery disease,
hypertension, renal disease, and hyperlipidemia is easy to
understand because hypertension and hyperlipidemia are 2
risk factors leading to metabolic syndrome, and renal dis-
ease is often a complication of DM. The proportion of
smokers was smaller among diabetics than nondiabetics in
our study as in several other studies.9,18,19 Probably due to
abetics after surgery for critical limb ischemia
Diabetics Nondiabetics
Pn % n %
95 15.7 336 10.5 0.001
64 6.5 106 3.3 0.001
21 8.8 180 5.6 0.001
53 2.1 41 1.3 0.05
40 1.6 30 0.9 0.05
11 4.5 110 3.4 0.05
30 9.2 331 10.3 ns
69 2.8 102 3.2 ns
87 3.5 107 3.3 ns
10 0.4 14 0.4 nsondi
3
1
2
1
2
AK,
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rate of chronic obstructive pulmonary disease. Because of
clear differences in preoperative risk profile, it was impor-
tant to adjust factors by using multivariate analysis. For
example, Akbari et al8 found significantly higher in-hospital
mortality in diabetics compared with nondiabetics after
lower-limb revascularization (0.9% vs 4.2%). However,
their data were not adjusted for different risk factors be-
tween the groups (eg, diabetics were 4 years younger that
nondiabetics). In our study, multivariate analysis enabled
control of the skewness of the comparisons between the
diabetics and nondiabetics.
The reason for higher morbidity and mortality among
diabetics is often widespread atherothrombotic disease.
According to Bierman20, about 75% of all deaths in diabet-
ics are due to atherothrombotic disease. Another well-
accepted observation is that patients undergoing major
vascular operations are at significant risk for perioperative
cardiac morbidity and mortality.15 Patients with DM have
been considered to have an elevated risk of cardiac compli-
cations compared with nondiabetics, which has necessi-
tated a lower threshold for cardiac stress testing.12
Unadjusted complication rates suggested that patients
with diabetes had a significantly higher rate of postopera-
tive deaths, cardiac complications, and cerebrovascular and
renal complications, as well as AK amputations and super-
ficial wound infection. Most of this incremental risk, how-
ever, depended on the higher levels of specific comorbidi-
ties among diabetic patients, such as hypertension,
hyperlipidemia, congenital heart disease, and renal insuffi-
ciency, as well as more severe ischemia as an indication for
the procedure. After adjusting these differences, there were
no significant differences in early postoperative cerebrovas-
Adjusted odds ratios with 95% CI from multiple logistic r
in diabetics compared to nondiabetics. BK, Below knee;cular and renal complication rates. In our multivariate
analysis DM alone was not an independent risk factor for
postoperative mortality either. After adjustment of preop-
erative and intraoperative factors in multivariate analysis,
the rate of postoperative cardiac complications remained
significantly higher in diabetics. Although the prevalence of
subclinical coronary artery disease in the diabetic popula-
tion is high, it may also be clinically silent in this population.
Autonomic neuropathy in diabetics may interfere with the
perception of cardiac pain and myocardial ischemia.21,22
Silent ischemia may also have an impact on postopera-
tive incidence of diagnosed myocardial ischemia. Thus, in
some cases, cardiac complication may remain undiagnosed
in diabetics. On the basis of registry data, it is naturally
impossible to suggest the number of possible undiagnosed
cases with silent ischemia.
Although DM does not appear to have independent
impact on postoperative mortality rates, diabetics have
several notable problems affecting their outcome after vas-
cular surgery procedures. The diagnosis of diabetic foot is
still difficult because of masking by neuropathy. That causes
delay in diagnosis and beginning of effective treatment.
Severity of preoperative tissue loss influences the outcome
of limb after reconstruction. If there is extensive tissue loss,
especially with deep infection, amputation can be inevitable
despite successful revascularization. Indeed, the high am-
putation rate, especially among diabetics with open grafts,
might be sign of the severity and extent of the disease.
In a Finnish study, despite successful revascularization,
limb salvage was not obtained in 8% of the patients with
CLI, as they were referred to vascular surgery too late.23 In
our study, the indication for the operation in diabetic group
was gangrene or ulceration more often than in nondiabetic
sion for postoperative complications in 30-day follow-up
above knee; MOF, multi organ failure.egres
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common indication. Incorrect distal pressure measure-
ments may also mislead in the diagnosis of critical leg
ischemia. Femorodistal bypasses are performed significantly
more often in diabetics compared with nondiabetics, which
is in accordance with more distal locations of arterial lesions
in diabetics than nondiabetics. More distal and severe arte-
rial occlusive disease is also one probable reason for the
higher 30-day BK-amputation rate following revasculariza-
tion that was seen in our study. Diabetes also remained an
independent risk factor for early BK amputation when the
differences in preoperative stage of ischemia were taken
into consideration. One of 3 graft occlusions led to ampu-
tation within 1 month in both diabetics and nondiabetics.
The acute graft occlusion rate was equal in both groups,
which further emphasizes the independent role of diabetes
in increasing the risk of amputation. In cases in which the
graft was patent at 30 days, significantly more diabetics than
nondiabetics underwent amputation. This supports the
suggestion that in diabetics reconstruction is often per-
formed too late, and that diabetics more commonly must
undergo amputation due to major tissue loss, despite suc-
cessful revascularization.
An interesting finding in our study was that urgent
operations were associated with higher mortality in diabet-
ics but not in nondiabetics. One reason might be the
concurrent severe infection more often associated with
emergency surgery in diabetics than in nondiabetics. Also,
in urgent cases preoperative patient evaluation, risk factor
assessment, and treatment may be more incomplete than in
elective cases. This might further increase the number
myocardial ischemic complications, especially in diabetics
with undiagnosed silent ischemia and glycemic imbalance.
Table VI. Multivariate analysis on the significance of preo
and nondiabetics
RR
Aortoiliac or aortofemoral reconstruction* 2.5†
Urgent compared with elective surgery 2.0†
Male gender 2.0†
Renal insufficiency 1.9†
Cardiac risk 1.7‡
Age (per 10 y) 1.4‡
Femoral endarterectomy* 1.7
Primary compared to secondary surgery 1.5
Pulmonal insufficiency 1.4
Femorodistal reconstruction* 1.4
Gangrena compared with rest pain 1.2
Ulcer compared with rest pain 1.1
Extra-anatomic bypass for central PAOD* 1.1
Hypertension 1.0
Smoking 1.0
Cerebrovascular disease 1.0
RR, Risk ratio; PAOD, peripheral arterial occlusive disease.
*Compared to femoropopliteal reconstruction.
†P  .05.
‡P  .001.Other factors that predicted mortality in diabetics but not
in nondiabetics were male gender and preoperative renal
insufficiency. In several studies, survival of males, both
diabetic and nondiabetic, has been found to be poorer than
in a matched normal population.24-27 In a study by Hil-
tunen et al,24 the 4-year survival rate for Finnish diabetic
men was 85% compared with 96% for diabetic women. In
our study we were able to compare only 30-day outcome, as
long-term data were not available, yet diabetic men seemed
to have higher early mortality than men without diabetes or
women with or without diabetes. Unfortunately, severity of
preoperative renal insufficiency cannot be determined from
Finnvasc data as all stages from moderately increased creat-
inine to end-stage renal disease with dialysis were clustered
together. Our suggestion is that diabetics have more severe
renal disease and that the proportion of dialysis patients
among those with preoperative renal risk factor is higher in
diabetics than in nondiabetics. Due to this, renal risk factor
would be associated with early postoperative mortality in
diabetics.
CONCLUSION
Diabetes is an independent risk factor for early postop-
erative myocardial ischemia, BK amputation, and wound
infection. Early diagnosis of CLI as a potential reason for
diabetic foot problems is of outmost importance. In diabet-
ics, preoperative cardiac assessment is mandatory even if
patient does not have diagnosed coronary artery disease or
classical symptoms. This should be remembered also in the
case of urgent operation, when preoperative time for assess-
ment can be limited.
tive factors for early postoperative mortality in diabetics
iabetics Nondiabetics
(95% CI) RR (95% CI)
(1.1–5.9) 4.5‡ (2.4–8.3)
(1.3–3.2) 1.4 (0.9–2.3)
(1.3–3.0) 0.8 (0.5–1.3)
(1.1–3.3) 1.9 (0.9–4.1)
(1.4–2.2) 3.6‡ (2.3–5.6)
(1.2–1.7) 1.0 (0.7–1.2)
(0.8–3.6) 0.4 (0.1–1.4)
(0.8–2.7) 2.6† (1.3–5.2)
(0.8–2.6) 1.1 (0.7–1.9)
(0.8–2.3) 1.0 (0.5–1.9)
(0.7–2.2) 1.2 (0.6–2.5)
(0.7–1.9) 1.2 (0.8–1.8)
(0.6–2.4) 2.3† (1.3–4.2)
(0.7–1.5) 0.7 (0.5–1.1)
(0.5–1.7) 0.9 (0.6–1.4)
(0.8–1.3) 1.4 (0.9–2.4)pera
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ABSTRACT
Background and Aims: Investigating the impact of percutaneous transluminal angio-
plasty (PTA) on clinical status and health related quality of life in patients with claudica-
tion and critical limb ischaemia (CLI).
Material and Methods: 61 patients and 64 limbs underwent a primary PTA (30 claudi-
cation and 34 CLI cases). Clinical status was graded according to Ahn and Rutherford
and ankle/brachial index (ABI). Quality of life was assessed using the Nottingham
Health Proﬁle (NHP) preoperatively, one month and one year after the procedure. Triplex
scan evaluation of the treated arterial segment was carried out postoperatively and one
year after the procedure.
Results: Claudication: 24/27 patients underwent one-year follow up, after which 20/24
had no claudication. In triplex evaluation 17 (63.0%) treated segments were open with
0–50% restenosis, 9 (33.3%) with 51–99% restenosis and one (3.7%) was occluded. CLI:
13/34 (38.2%) patients underwent one-year follow-up after which eight patients (61.5%)
were asymptomatic and ﬁve (38.1%) had claudication. In triplex evaluation there was
0–50% restenosis in 6 (46.2%) segments treated with PTA and 51–99% restenosis in 7
(53.8%) segments. 21 (61.8%) patients did not conclude the one year follow up: 7 had died,
5 had undergone bypass surgery and 6 an amputation and 3 did not attend the follow-up
up for unknown reasons. Quality of life: For CLI patients, improvement was observed
in the domain of pain, which continued throughout the follow-up period. Among the
claudicants, the domain of physical mobility was improved at one month’s follow-up,
but this effect disappeared during the following year and could not be seen at one the
one- year follow-up.
Conclusions: Technical success and one-year results in claudication are good, and the
rate of complications is low. However, although PTA resulted in an immediate improve-
ment in the quality of life, this effect was not seen in the long term. In critical limb
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ischemia there was a group of patients in whom PTA led to a signiﬁcant beneﬁt in terms
of limb salvage and quality of life.
Key words: Intermittent claudication; critical limb ischaemia; percutaneous transluminal angioplasty;
quality of life; claudication; vascular surgery
INTRODUCTION
Endovascular treatment of chronic lower limb
ischemia is less invasive and usually achievable at the
time of angiography. Patients with claudication often
have smaller atherosclerotic manifestations than
those with critical limb ischemia (CLI), and moderate
lesions can often be treated with percutaneous trans-
luminal angioplasty (PTA). In patients with CLI and
widespread atherosclerotic lesions, endovascular
treatment is rarely possible and bypass reconstruc-
tion is usually preferred. However, the risks of open
surgery are unacceptable for some patients. In these
cases, PTA may offer an alternative for avoiding am-
putation. The crucial question is, what the effective-
ness and patency of PTA is in the long term. Does it
prevent amputations in patients with critical limb
ischemia or increase the quality of life for a claudi-
cants?
The impact of PTA on the quality of life (QoL) of
claudicants has been indeﬁnite (1), and the QoL stud-
ies with CLI patients are based mainly on bypass
surgery treatments (2). Moreover, the success of in-
tervention has been described in terms of graft pa-
tency and limb salvage (3).
In this prospective, nonrandomized study, we ana-
lyse the haemodynamic results of PTA, and evaluate
the quality of life of the patients before and after the
PTA procedure.
MATERIAL AND METHODS
A total of 61 consecutive patients and 64 limbs underwent
a primary PTA procedure in a teaching hospital of an aca-
demic institution during a period of 18 months. The study
was approved by the local ethics committee, and written
consent to participate was obtained in all cases. Data were
collected prospectively. Clinical criteria for categories of
chronic limb ischemia were outlined according to Ahn and
Rutherford (4). The clinical grades I (claudication), II (isch-
emic rest pain) and III (tissue loss) account for the different
natural histories of each group. Ankle/brachial index (ABI)
was used as a noninvasive hemodynamic assessment to-
gether with triplex scan evaluation performed immediate-
ly and one year after the PTA procedure. Quality of life was
assessed using the Nottingham Health Proﬁle (NHP) de-
veloped by Hunt and McEwen (5), and the Finnish version
was employed in this study (6). The NHP is a two-part in-
strument, and part I was used. The 38 yes/no items reﬂect
the patient’s degree of distress within the domains of pain,
physical mobility, emotional reactions, energy, social isola-
tion and sleep. The answer is given as a score between 0
and 100 describing the degree of harm in each item. The
NHP questionnaire was ﬁlled out before the PTA procedure
as well as one month and one year after the procedure.
The clinical characteristics of patients are summarized
in Tables 1 and 2.
The data were statistically analysed using the SPSS
software. Mean values of the variables between clau-
dicants and CLI patients were compared using the
independent samples t-test or the Mann-Whitney test.
The means of the preoperative, 30-days follow-up
and one-year follow-up values were compared using
the dependent samples t-test or the Wilcoxon test and
general linear models for repeated measures.
ENDOVASCULAR TECHNIQUE
All interventions were performed under local anaesthesia
using the standardized technique. Access to the iliac lesions
was obtained via an ipsilateral retrograde puncture of the
common femoral artery and to the femoropopliteal and
crural lesions via an ipsilateral antegrade puncture. The
sheet was always used. Intravenous heparin (5000 units)
was administered prior to the PTA. Technical success was
deﬁned as residual stenosis with less than 30% lumen re-
duction. Stents were used in 22 of the 25 iliac lesions, half
of which were self-expandable nitinol and the remaining
half balloon- expandable stainless steel stents. In 2 of 15
femoral lesions, nitinol stents were used due to unsatisfac-
tory primary results with a balloon. All patients received
aspirin (100 mg daily) after the procedure.
TABLE 1
Characteristics of the subjects treated with angioplasty for critical limb
ischemia (61 cases; mean age ± SD: 71.8 ± 10.9 years).
Variable n %
Male 39 64
Female 22 36
Coronary artery disease 25 41
Diabetes mellitus 34 56
Hypertension 37 61
Smoking 16 26
Hyperlipidaemia 16 26
Renal insufﬁciency 3 5
Cerebrovascular disease 9 15
Chronic obstructive lung disease 7 11
TABLE 2
Characteristics of the limbs treated with angioplasty.
Variable n (stent) %
Indication for PTA
Claudication 30 (22) 47
Ischemic rest pain 10 (22) 16
Ulcer / gangrene 24 (22) 37
The most distal artery treated
Iliac artery 25 (22) 39
Superﬁcial femoral artery 15 0(2)
Popliteal artery 13 (22) 39
Crural arteries 11 (22) 22
PTA: Percutaneus transluminal angioplasty
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SONOgRAPHy
The vessels were examined after revascularization with
Color Flow Duplex sonography. The site of the PTA and
stent was located with colour and the grade of the residual
stenosis was measured. In addition, the haemodynamic
status was analysed with pulsed wave Doppler sonogra-
phy, and the possible residual stenosis was estimated using
the peak ﬂow and the Doppler waveform. The examination
was carried out by two independent radiologists who did
not participate in the PTA procedures.
RESULTS
CLAUDICATION
Twenty-seven claudication patients and 30 limbs
were treated, with a mean preoperative ABI of 0.63.
The mean age of the claudication patients was 69.3
years (SD 10.7). One patient sustained a complication
(1/27, 3.3%), stroke, the day of the PTA. All limbs
underwent triplex-ultrasound after the PTA. 20/30
(66.7%) of the treated areas were open with 0–50%
residual stenosis, and 10 limbs had residual stenosis
of 51–99%. None of the sections treated were oc-
cluded. 26 patients underwent a 30-day clinical fol-
low-up. One patient did not arrive at the 30-day con-
trol but did attend the one-year control with no clau-
dication, the treated segment open with 0–50% reste-
nosis and ABI 1.02 in the treated limb. At 30 days,
22/26 (84.6%) patients with a total of 27 treated limbs
had no claudication, and 3/26 (11.5%) had claudica-
tion. The mean ABI in patients who underwent 30-
day follow-up increased from the preoperative 0.63
to 0.84. 24 patients and 27 treated limbs underwent
one-year follow-up, including a clinical control visit
and triplex-ultrasound: 21/24 (87.5%) had no claudi-
cation, and 3/24 (12.5%) had claudication which had
been present throughout the one-year follow-up pe-
riod. Triplex ultrasound showed that 17/27 (63.0%)
controlled sections were open with 0–50% restenosis,
9/27 (33.3%) were observed to have 51–99% resteno-
sis, and 1/27 (3.7%) PTA segment was occluded. The
mean ABI in these patients was 0.63 preoperatively
and 0.85 at one year’s follow-up. Three patients did
not attend the control examination: one patient was
in a very poor general condition and did not wish to
attend the follow-up, and 2 patients did not come to
the one-year control despite several calls, the reason
for which remained unknown.
CRITICAL LIMB ISCHEMIA
Thirty-four patients (and 34 legs) with critical limb
ischemia underwent PTA during the study period.
The mean preoperative ABI of patients treated was
0.56, and the mean age of the CLI patients was 75.7
years (SD 10.1). The indications were ischemic rest
pain for 10 (29.4%) and ulceration or gangrene (tissue
loss) for 24 (70.6%) patients. Two patients (5.9%) sus-
tained a complication postoperatively a groin haema-
toma which did not require intervention in either
case. All patients underwent triplex-ultrasound one
day after the PTA. 13/34 (38.2%) segments were open
with residual stenosis of 0–50% in 20/34 (58.8%) there
was residual stenosis 51–99%, and one of the treated
sections occluded immediately. 27 of the 34 patients
underwent 30-day clinical follow-up. At 30 days,
6/34 (18.6%) patients were asymptomatic and 9/34
(26.5%) had claudication, one patient (2.9%) rest pain
and 11/34 (32.4%) patients an ulceration. Seven pa-
tients did not undergo 30-day follow-up for the fol-
lowing reasons: one patient underwent bypass recon-
struction, two patients died, three patients had an
amputation, and one patient did not attend despite
several invitations. The mean ABI in patients who
underwent 30-day follow-up increased from 0.54 to
0.67.
13 patients underwent one-year follow-up includ-
ing a clinical control visit and triplex-ultrasound.
None of them suffered from critical limb ischemia at
that time: eight patients were asymptomatic and ﬁve
had claudication. In one-year triplex control, six pa-
tients had restenosis of 0–50% in the PTA-treated ar-
terial segment, and seven patients had 51–99% reste-
nosis. No occlusions were observed. Among the 13
patients who underwent one-year follow-up, ABI had
increased from the preoperative 0.56 to 0.86 at one
year’s follow-up. 21 patients did not undergo one-
year follow-up: seven patients had died, six patients
underwent an amputation, and bypass surgery was
performed on ﬁve patients. Three patients did not
observe the invitation to attend the control examina-
tion, one of whom was in institutional health care
and in a very poor condition at the time.
PTA LEVEL
Results according to anatomic level of PTA are pre-
sented in Table 3.
QUALITy OF LIFE
Quality of life was measured preoperatively, at 30
days’ follow-up and at one year’s follow-up. There
were only 14 claudicants and 7 CLI patients who an-
swered the questions on all occasions. In Table 4 the
means in each subgroup are compared to the mean of
the population (value in the ﬁrst column), and sig-
niﬁcant differences are found. The 36 different tests
have not been combined; the results have been inter-
preted separately. The last three columns represent
the signiﬁcances of the pairwise comparisons in the
general linear models for repeated measures, compar-
ing the values at three different points in time. In the
domains of energy and pain, claudicants seemed to
improve their value after one month, but these
changes were not quite statistically signiﬁcant, and at
one year’s follow-up, the scores were signiﬁcantly
worse than at one month’s follow-up. For both clau-
dicants and CLI patients, the mean value for energy
is even worse at one year’s follow-up than preopera-
tively, but the difference is not statistically signiﬁcant.
For CLI patients, improvement was seen in the do-
main of pain, which continued at both follow-up
points, and the difference was statistically signiﬁcant
between the one-year follow-up and the preoperative
score. In the domain of sleep, there was signiﬁcant
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improvement for claudicants at one month’s follow-
up, and it continued until the one-year follow-up was
concluded. For CLI patients, the improvement was
not so clear, but they also reported signiﬁcantly im-
proved values at one year’s follow-up than pre-
operatively. Among claudicants, the domain of physi-
cal mobility was signiﬁcantly better at the one-month
point than preoperatively, but at the one-year follow-
up, the improvement had nearly disappeared and the
score was no longer signiﬁcantly better than pre-
operatively.
DISCUSSION
The role of PTA in the treatment of limb-threatening
ischaemia has increased signiﬁcantly during the last
ﬁve years. At the end of the last decade, the general
opinion was that the PTA should not be considered
as a primary treatment for CLI except in extraordi-
nary circumstances (7). The effectiveness of PTA in
the treatment in aortoiliac occlusive disease and clau-
dication has been well established since the early
1990s (8,9). The enthusiasm towards PTA due to im-
provements in endovascular technology and exper-
tise has led to suggestions that PTA should be the ﬁrst
choice for most of the patients requiring lower-ex-
tremity revascularization (10–12). In patients with
claudication and relatively short lesions in arteries
proximal to the popliteal artery, the clinical beneﬁts
of PTA compared to bypass surgery are clear: there is
no need for general or spinal anaesthesia, the disad-
vantages of reconstructive surgery including surgical
wounds are avoided, the hospital stay is shorter and
TABLE 3
One-year patency of PTA according to anatomy and extension of the lesion.
Claudication Residual stenosis (%)
N 0–50 51–99 occluded not controlled
Iliac artery 17 12 3 0 2
Femoropopliteal 13 05 6 1 1
Tibial arteries 00 00 0 0 0
Critical limb ischemia Residual stenosis (%)
N orig 0–50 51–99 occluded not controlled
Iliac artery 82 2 0 4
Femoropopliteal 11 1 0 0 10
Tibial arteries 15 3 5 0 07
TABLE 4
The quality of life in patients who underwent PTA (F = Fontaine).
Preoperatively (1st) 1 month (2nd) 1 year (3rd) Differences between
measurements in time: (P) for
Control
1
Mean (Std.D) n (P)
2
Mean (Std.D) n (P)
2
Mean (Std.D) n (P)
2
1st vs 2nd 2nd vs 3rd 1st vs 3rd
Energy 17.30
F II 25.14 (32.63) 21 (n.s.) 21.91 (29.13) 18 (n.s.) 33.67 (38.82) 23 (n.s.) (n.s.) (0.004) (n.s.)
F III–IV 33.93 (31.41) 22 (0.022) 26.68 (28.93) 17 (n.s.) 42.76 (42.91) 11 (n.s.) (n.s.) (n.s.) (n.s.)
Sleep 21.90
F II 36.95 (31.39) 21 (0.040) 31.72 (32.24) 18 (n.s.) 26.13 (29.93) 23 (n.s.) (n.s.) (n.s.) (0.010)
F III–IV 40.69 (35.67) 24 (0.017) 32.45 (32.82) 15 (n.s.) 18.37 (19.94) 11 (n.s.) (n.s.) (n.s.) (0.015)
Pain 17.90
F II 38.33 (24.25) 21 (0.001) 24.56 (28.55) 19 (n.s.) 33.08 (24.20) 22 (0.008) (n.s.) (0.006) (n.s.)
F III–IV 42.43 (33.89) 24 (0.002) 26.11 (33.52) 16 (n.s.) 23.18 (17.54) 11 (n.s.) (n.s.) (n.s.) (0.037)
Emotional
reactions 11.30
F II 17.01 (27.56) 21 (n.s.) 10.99 (18.56) 19 (n.s.) 12.18 (22.55) 22 (n.s.) (n.s.) (n.s.) (n.s.)
F III–IV 21.08 (27.31) 25 (n.s.) 14.52 (25.83) 17 (n.s.) 10.50 (18.54) 11 (n.s.) (n.s.) (n.s.) (n.s.)
Social
isolation 17.40
F II 07.99 (18.23) 22 (0.025) 10.07 (14.89) 19 (0.046) 09.71 (14.12) 22 (0.018) (n.s.) (n.s.) (n.s.)
F III–IV 11.19 (14.21) 27 (0.032) 08.71 (11.33) 17 (0.006) 1.49 0(4.94) 11 (0.000) (n.s.) (n.s.) (n.s.)
Physical
mobility 17.70
F II 35.92 (27.60) 19 (0.010) 18.09 (21.02) 19 (n.s.) 27.09 (24.41) 23 (n.s.) (0.007) (0.005) (n.s.)
F III–IV 41.68 (28.23) 26 (0.000) 28.74 (28.00) 16 (n.s.) 30.08 (27.23) 11 (n.s.) (n.s.) (n.s.) (n.s.)
1
mean in age matched control population
2
P-value in testing difference between mean and control
1
value
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the rates of complications and mortality are low. (12,
13). However, the role of PTA for CLI is still contro-
versial. Furthermore, an aspect that is at least as im-
portant as technical success and patency for claudica-
tion patients is the change in the quality of life of
these patients.
The technical success of PTA procedures is high
and the clinical result of the treatment can be mea-
sured in an objective manner by noninvasive meth-
ods. In the current study, the technical success was
100%, and postoperative complications were rare.
Only one patients sustained a serious complication,
stroke, and he recovered well with no permanent
symptoms. Furthermore, the clinical success for clau-
dication patients was good: only 1 PTA segment was
occluded at one-year follow-up and more than 80%
of patients were free of claudication.
Patients with critical limb ischemia (CLI) differ sig-
niﬁcantly from those suffering from claudication.
CLI-patients may have a widespread atherosclerotic
disease and serious risks regarding open surgery. On
the other hand, some CLI patients may be suitable for
both endovascular and open reconstructive treat-
ment. As a whole, the present study demonstrates the
poor outcome of CLI patients with high mortality and
morbidity rates. However, one third of the CLI pa-
tients survived with no critical ischemia at one-year
follow up. Those patients with rest pain seem to gain
more beneﬁt, whereas the outcome was poorer in legs
with tissue loss.
Proof of the efﬁcacy of the procedure has been re-
quested, as the current evidence regarding QoL fol-
lowing PTA is equivocal especially among claudi-
cants (14, 15). Several generic quality of life instru-
ments have recently been tested and used among
vascular surgery patients. In this study, NHP was
chosen, because at the time when the study was initi-
ated, it was one of the few instruments that had been
translated into Finnish and valuated and validated
for the Finnish population (6). The NHP has been
shown to be reliable among vascular surgery patients
in earlier studies (2). Klevsgård et al. (2) demon-
strated that the NHP was better than the Short-Form
36 Health Survey (SF-36) for patients with lower limb
ischaemia with regard to pain and physical mobility
and our experience is that the NHP was very effective
in those domains.
Filling out the NHP questionnaire independently
proved to be difﬁcult or even impossible for many of
our patients especially among the CLI-patients who
are older and whose more serious illness causes var-
ying levels of disability. Problems with reading or
writing are reﬂected in the willingness to ﬁll out a
long questionnaire. Some of he NHP questions in-
volving the domain of social isolation caused embar-
rassment to the patients and the results of the ques-
tionnaire in that domain are not reliable. Chronic
neurological brain diseases such as dementia and
Alzheimer’s disease makes the evaluation of the
quality of life impossible with any questionnaires.
Because of these problems, we had to exclude im-
properly ﬁlled out forms, which has caused some
selection in our results.
The responses in the domains of energy, sleep, pain
and physical mobility were more reliable than those
given with reference to emotional reactions and social
isolation. Our assessment is that patients found it
easier to answer these questions. Because there were
only 11 patients with CLI at one-year follow-up who
were able to answer the questions, the differences
between the mean values did not reach statistical sig-
niﬁcance. In the domain of energy, an improvement
could be seen in both groups, CLI and claudication,
but this was statistically signiﬁcant only for the clau-
dicants. This improvement disappeared during the
following year, and indeed the value worsened com-
pared to the preoperative situation. The same phe-
nomenon could be seen in the domain of pain for
claudicants. One explanation might be that the disap-
pearance of claudication pain improved the value at
the one-month control but the patients forgot this
beneﬁt during the following year. The patients suf-
fered from many other co-morbidities that affected
the results in the domain of energy. In CLI patients,
the scores in the domain of pain improved postop-
eratively and the improvement continued up to the
one-year control. The improvement was statistically
signiﬁcant when the preoperative scores and the situ-
ation at one-year’s follow-up were compared.
In the domain of physical mobility, the improve-
ment for claudicants was clear and statistically sig-
niﬁcant up to the one-month follow-up, but again this
improvement nearly disappeared during the follow-
ing year. In the CLI group, there were no changes in
the QoL value of mobility, which can be understood
in that poor general health in CLI patients causes im-
mobility along with limb ischemia and although leg
salvage is achieved, patients stay relatively immo-
bile.
The role of PTA in the treatment of CLI remains
unclear. In the present data, the one-year outcome of
CLI patients was relatively poor. Morbidity and mor-
tality are low after endovascular procedures, but the
risks and the rate of complications are high, including
cardiac events and local morbidity (11, 12, 16). There-
fore it is a signiﬁcant ﬁnding that a subgroup of CLI
patients gained a clear improvement which remained
one year after PTA.
Claudication patients are generally believed to
beneﬁt from PTA. Although our one year clinical re-
sults and technical success were good, as almost 90%
of the patients were free from claudication, the qual-
ity of life seemed to have deteriorated to the pre-
operative level with regard to the domains of pain
and physical mobility. Whyman et al. (17) reported
no correlation between improved ABI, walking dis-
tance and quality of life score at 6 months, except
with regard to pain, among claudicants treated with
angioplasty. Chetter et al. (1) similarly observed in
their study that unilateral claudicants undergoing
PTA on a solitary iliac lesion demonstrated the most
marked QoL beneﬁts and, 12 months post-PTA, re-
ported a QoL approaching that of an age-matched
population. In contrast, Klevsgård (2) reported that
successful treatment of chronic limb ischaemia im-
proved the quality of life for claudicants in their six-
month follow up study.
Discrepancies between the technical success of
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PTA, improvement in Fontaine classiﬁcation and
long-term improvement in the quality of life indicates
that there are no reliable methods to analyse the ef-
fects of PTA-procedures in the treatment of claudica-
tion. Our study raises the question whether the treat-
ment of claudication provides any long term im-
provement in quality of life.
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ABSTRACT
Background and Aims: The ability to predict post-operative mortality reliably will be of
assistance in making decisions concerning the treatment of an individual patient. The
aim of this study was to test the GAS score as a predictor of post-operative mortality in
vascular surgical patients.
Material and Methods: A total of 157 consecutive patients who underwent an elective
vascular surgical procedure were included in the study. The Cox proportional hazards
model was used in analyzing the importance of various preoperative risk factors for the
postoperative outcome. ASA and GAS were tested in predicting the short and long-term
outcome. On the basis of the GAS cut-off value 77, patients were selected into low-risk
(GAS low: GAS < 77) and high-risk (GAS high: GAS > = 77) groups, and the examined
risk factors were analyzed to determine which of them had predictive value for the prog-
nosis.
Results: None of the patients in the GAS low group died, and mortality in the GAS
high group was 4.8% (p = 0.03) at 30 days’ follow-up. The 12-month survival rates were
98.6% and 78.6% (p = 0.0001), respectively, with the respective 5-year survival rates of
76.7% and 44.0% (p = 0.0001). The only independent risk factor for 30-day mortality was
the renal risk factor (OR 20.2). The combination of all three GAS variables (chronic renal
failure, cardiac disease and cerebrovascular disease), excluding age, was associated with
a 100% two-year mortality.
Conclusions: Mortality is low for patients with GAS < 77. For the high-risk patients
(GAS > = 77), due to its low predictive value for death, GAS yields limited value in
clinical practice. In cases of patients with all three risk factors (renal, cardiac and cere-
brovascular), vascular surgery should be considered very carefully.
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INTRODUCTION
A number of rating systems have been developed to
predict operative risks and postoperative mortality
in surgical patients. Because of their complexity, there
has been a need to ﬁnd a model for assessing opera-
tive risk that is easy to both calculate and use. Samy
et al. (1,2) derived and validated a simple scale, the
Glasgow Aneurysm Score (GAS), for risk stratiﬁca-
tion of patients undergoing elective and emergency
open repair of an abdominal aortic aneurysm (AAA).
In the study by Biancari et al. (3), GAS proved to be
a good predictor of mortality after elective open re-
pair of an AAA, in addition to its simplicity and ac-
curacy. Most of the related studies have evaluated the
value of risk scores in predicting operative mortality
and morbidity. However, long-term outcome is also
important when surgical procedures are planned for
the patients. In the case of poor long-term mortality,
the patient may not gain the beneﬁt from the proce-
dure and the operation may even cause more harm
than non-surgical treatment. These facts raised the
question whether the operative risks and long-term
mortality of vascular surgery patients could generally
be predicted with risk scoring methods. The aim of
the current study was to evaluate the importance of
different risk factors for the mortality of vascular pa-
tients, in addition to assessing the usefulness of the
GAS and ASA classiﬁcations in predicting the imme-
diate postoperative and long-term mortality of pa-
tients undergoing vascular surgery.
MATERIAL AND METHODS
A total of 157 consecutive patients who underwent an elec-
tive vascular surgical procedure in a teaching hospital be-
tween 9 April 2002 and 9 April 2003 were included in the
study. The study was approved by the local ethics commit-
tee, and written consent to participate was obtained in all
cases.
Data was collected prospectively. The data recorded com-
prised a patient history from case reports, anamnesis and
physical examination as well as electrocardiography (ECG),
chest radiography and basic laboratory testing including
serum creatinine and haemoglobin levels. The preopera-
tive examination and data collection were performed by a
vascular surgeon or vascular surgical fellow, and the ASA
(American Society of Anesthesiologists) score was deter-
mined by an anaesthetist.
Patients were divided into three groups according to the
indication for surgery: carotid procedures for cerebrovas-
cular circulation, chronic limb ischaemia and abdominal
aortic aneurysm.
The Glasgow Aneurysm Score (GAS) was calculated us-
ing the formula: risk score = age in years + 7 (for myocar-
dial disease) + 10 (for cerebrovascular disease) + 14 (for
renal disease) (1, 2). Myocardial disease refers to a previ-
ously documented myocardial infarction and/or ongoing
angina pectoris. Cerebrovascular disease refers to all grades
of stroke including transient ischaemic attack (TIA). Renal
disease refers to a history of chronic and acute renal failure,
and/or a serum level of creatinine greater than 140 µmol/l
at the time of surgery. Patients were divided into two GAS
groups based on the study by Hirzalla et al. (4): GAS < 77
(GAS low) and GAS > = 77 (GAS high).
A postoperative renal complication was deﬁned as an
increase in the serum concentration of creatinine or urea
that required medical treatment or dialysis. A postoperative
cardiac complication was deﬁned as a myocardial infarction
(ECG changes or increased serum troponin level) or death
due to cardiac causes, as well as postoperative cerebro-
vascular complications such as a TIA or stroke. Long-term
mortality data up to 5 years postoperatively were obtained
from the cause of death registry of Statistics Finland. No
patients were lost from the follow-up.
The data were statistically analysed using the SPSS 13.0
software. Data are expressed as mean value and standard
deviation. The Chi-Square test, logistic regression as well as
the Cox proportional hazards model and the Kaplan-Meier
Survival Analysis were used in data analysis.
RESULTS
Demographic data of the patients are presented in
Table 1. The most common indication for the proce-
dure was chronic limb ischaemia (60.5%, 95/157), fol-
lowed by carotid disease (26.1%, 41/157) and abdom-
inal aortic aneurysm (13.4%, 21/157).
The 30-day mortality rate was 2.5% (4/157). The
incidence of postoperative complications is presented
in Table 2. The only independent risk factor for 30-
day mortality was the renal risk factor (OR 20.2) (Ta-
ble 3A). None of the patients in the GAS low group
died, and the mortality rate in the GAS high group
was 4.8% (p = 0.03).
During the 5 years following the procedure, 40.8%
(64/157) of the patients died. In the Cox proportional
hazards model, independent predictors for long-term
mortality included the renal risk factor (OR 3.9), the
cardiac risk factor (OR 2.3), age (OR 1.04/year) and
TABLE 1
The characteristics of the patients
Patients (n = 157)
Mean age / SD 69.9 / 9.3
Male:female (%) 66 : 34
Hyperlipidemia
1
36.1
Hypertension
2
43.7
Cardiac
3
25.9
Cerebrovascular
4
37.3
Pulmonal
5
18.4
Renal
6
6.9
Smoking
7
36.1
Diabetes 27.2
GAS < 77 / > = 77 73 / 84
Mean GAS / SD 75.7 / 11.6
ASA 1 / 2 / 3 / 4 0 / 10 / 109 / 37
1
Serum concentration of cholesterol > 5.0 mmol/L or LDL > 3.0
mmol/L or triglycerides > 2.0 mmol/L
2
Medication for hypertension or arterial pressure > 145/85 mm
Hg
3
NYHA III–IV
4
History of stroke or transient ischaemic attacks
5
Asthma or chronic obstructive pulmonary disease
6
History of chronic and acute renal failure, or a serum level of
urea over 20 mmol/L or serum level of creatine over 140
µmol/L
7
Current smoker
8
Glasgow Aneurysm Scale
9
American Society of Anesthesiologists
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procedure type (carotid surgery as a reference cate-
gory: OR for an infrainguinal procedure 3.5 and for
infrarenal aorta 3.3) (Table 3B). 12-month survival for
the patients in the GAS low and GAS high groups
was 98.6% and 78.6%, respectively (p < 0.0001), the
respective 5-year ﬁgures being 76.7% and 44.0%
(p = 0.0001). All 4 patients with renal disease, cardiac
disease and cerebrovascular disease died within
2 years of the procedure. The Kaplan-Meier survival
rates for patients according to the renal risk factor,
TABLE 2
Complications of the patients during 30-day follow up. The number of
complications leading to death is marked in parentheses together with
the main indication for the operation.
Complication Patients
(n = 157)
Cardiac ischaemia 6 (2 deaths, leg ischae-
mia)
Acute renal failure 4
Acute graft occlusion 8
Disrupted laparotomy wound 2
Respiratory complication 8 (1 death, leg ischaemia)
Cerebrovascular complication 5
Superﬁcial wound infection 15
Deep wound infection 2
Bowel ischaemia 4 (1 death, AAA)
Postoperative haemorrhage 9
Reversible nerve damage 6
G-I bleeding 1
TABLE 3A
Multivariate analysis of the risk factors for 30-day postoperative mortality. Dependent factor: 30-day mortality.
Independent factors: Age, sex, operation type (carotid artery, infrarenal aorta, infrainguinal arteries); and preoperative
risk factors: cardiac, renal, cerebrovascular, diabetes
FACTOR OR 95% CI P
Aortic surgery *(compared to carotid surgery) na na na
Infrainguinal surgery* (compared to carotid surgery) na na na
Age per 10 years 03.1 00.8–11.9 0.09
Cardiac risk 00.8 0.1–5.1 0.80
Renal risk 20.3 .3.1–133 00.002
Cerebrovascular risk 02.1 0.3–15. 0.40
Diabetes 00.8 0.1–6.5 0.70
Sex (male vs. female) 00.2 0.02–1.80 0.10
na = not applicable
* no values because 30-day mortality for carotid surgery was 0%
TABLE 3B
Cox proportional hazards model for long-term mortality after a vascular surgical procedure. Dependent factor: Mortality during 5 years after the
procedure. Independent factors: Age, sex, operation anatomy (carotid artery, infrarenal aorta, infrainguinal arteries) and preoperative
risk factors: cardiac, renal, cerebrovascular, diabetes
FACTOR OR 95% CI P
Aortic surgery (compared to carotid surgery) 3.3 1.2–9.6 0.004
Age per 1 years 01.04 1.01–1.10 0.020
Infrainguinal surgery (compared to carotid surgery) 3.5 1.4–8.8 0.007
Cardiac risk 2.3 1.3–3.8 0.002
Renal risk 3.9 1.7–9.0 0.002
Cerebrovascular risk 1.0 0.6–1.9 0.900
Diabetes 0.7 0.6–2.0 0.700
Sex (male vs. female) 0.6 0.3–1.2 0.100
the ASA classiﬁcation and GAS are presented in Fig-
ure 1.
DISCUSSION
To ensure appropriate use of health care resources
and avoid futile attempts at intervention in patients
with high risk, the role of judicious patient selection
is essential. On the other hand, the intuition of an
experienced surgeon is generally based on quite obvi-
ous clinical symptoms. A number of scoring systems
have been developed to predict outcome for patients
and to assist in the decision-making in a more objec-
tive way, therefore justifying the procedure. The
Physiological and Operative Severity Score for the
enumeration of mortality and morbidity (POSSUM)
(5, 6) is widely used among surgeons and can surely
be considered a standard method, but its suitability
for vascular surgical procedures (V-POSSUM), espe-
cially aortic aneurysm surgery (RAAA-POSSUM),
has been doubted (7, 8). Furthermore, the POSSUM
score was originally designed to support comparative
audit and has not been recommended for outcome
prediction. Moreover, it is relatively difﬁcult to use in
daily practice.
In the present study, the GAS cut-off value was
determined at 77 according to Hirzalla et al. (4), di-
viding the patients into low and high-risk groups. A
risk score of less than 77 predicted a fairly low mor-
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Fig. 1. Kaplan-Meier 5-year survival in low-risk and high-risk pa-
tients according the GAS classiﬁcation (A) (1 = GSA low; 2 = GAS
high), according to the ASA classiﬁcation (B) and in patients with
or without renal insufﬁciency (C) (Cut-off value for serum creati-
nine 140).
A B
C
tality after procedures, while a risk score of higher
than or equal to 77 was clearly associated with a
higher mortality. However, the use of this method in
clinical practice is limited. GAS has a good predictive
value for patients who survive, but it is not as accu-
rate in attempting to identify those patients who do
not survive the operation or whose life expectancy
after the procedure is limited.
Multivariate analysis of short-term mortality dem-
onstrated that although renal insufﬁciency is a sig-
niﬁcant risk factor, diabetes alone without renal com-
plications does not signiﬁcantly increase the incidence
of short-term mortality. With regard to long-term
mortality in our study with ﬁve years’ follow-up, re-
nal insufﬁciency alone was connected with high mor-
tality: none of these patients survived the follow-up
period of ﬁve years. Cardiac disease appeared to be
a strong risk factor in addition to renal insufﬁciency
and age. The combination of all three GAS variables,
with the exception of age, yielded an extremely high
mortality rate: all of these patients died within two
years’ follow-up. Although the number of these pa-
tients was low – only four – the message is clear that
these patients are at an extremely high risk after vas-
cular surgery. What was interesting was that the sur-
vival rate for ASA 2 and ASA 3 patients was almost
the same, being signiﬁcantly better than among the
ASA 4 patients. Because the number of ASA 2 pa-
tients was only 10, however, any strong conclusions
cannot be made.
When comparing different types of surgical proce-
dures, the group of carotid endarterectomy (CEA)
patients seemed to manage better during a ﬁve-year
follow-up than the groups of infrarenal aortic and
Patients at risk
Renal no 146 135 129 122 109 76
Renal yes 11 3 2 1 1 0
Patients at risk
GAS low 73 72 70 67 63 45
GAS high 84 66 61 56 47 31
Patients at risk
ASA2 10 9 9 9 7 5
ASA3 110 101 98 93 84 57
ASA4 37 26 22 18 16 8
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infrainguinal patients, although carotid patients were
signiﬁcantly older than those included in other
groups. In addition, GAS was higher for carotid pa-
tients due to the high age and to cerebrovascular dis-
ease of which nearly all of them suffered. However,
the carotid patients had a lower incidence of cardiac
and renal disease. Furthermore, although they had
cerebrovascular disease, this risk decreased when the
carotid stenosis was treated surgically. Therefore, the
CEA risk assessment differs from the risk assessment
for the other groups, and the importance of cerebro-
vascular disease should be considered in a different
light for these patients.
Our study showed that GAS has predictive value
for the prognosis after vascular surgical procedures,
because the survival from infrarenal aortic and in-
frainguinal procedures was similar, and there is a
need to perform external validation of GAS in vascu-
lar surgery procedures. Our estimation is that GAS is
highly valid for the high-risk group even at the se-
lected cut-off GAS score of 77 and that the individual
high-risk patient requires special attention. Thereaf-
ter, GAS has good negative predictive value for vas-
cular surgery patients. The observations are in line
with other studies concerning AAA surgery (4, 9)
In vascular surgery, mortality is not an outcome
measure except in aneurysm surgery, where the aim
of the surgery is to avoid aneurysm rupture and
death. In the treatment of critical limb ischaemia, the
aim is to prevent amputation and thus maintain the
patient’s mobility and independence. In carotid sur-
gery, the reasons for operating are to prevent stroke
and death due to stroke. Surgery should be performed
despite high risks if the patient’s life expectancy is
more than one year. If the life expectancy is very
short, however, an operation causes unacceptable in-
dividual suffering for all patients. The aim of this
kind of study is to help us distinguish patients at an
extremely high risk. The number of patients included
in the current investigation is too low to make any
far-reaching conclusions, but some of the ﬁndings
may be useful in evaluating individual patients in
everyday clinical work.
CONCLUSION
Mortality is low among patients with GAS < 77. How-
ever, for the high-risk patients (GAS > = 77), due to its
low predictive value for death, GAS yields limited
value in clinical practice. In cases of patients with all
three risk factors (renal, cardiac and cerebrovascular),
vascular surgery should be considered very care-
fully.
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